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ABSTRACT 
Introduction 
Vigilance in obstructive sleep apnoea (OSA) does not correlate well with measures of 
severity of the disease or symptoms. There is a need for a simple objective test to 
identify patients with reduced vigilance. One such method could be quantitative 
analysis of the awake electroencephalogram (qEEG). 
qEEG is conventionally analysed using Power Spectral Analysis (PSA) looking at 
different EEG frequencies of delta, theta, alpha and beta. A novel method of analysing 
the qEEG: De-trended fluctuation analysis (DFA) provides a single value: the scaling 
exponent (SE), which measures the fluctuations in the EEG signal. DFA SE and PSA 
are two different measurements (measuring fluctuations of EEG versus EEG 
frequencies respectively) used to examine the same effect: EEG slowing, which implies 
increased drowsiness. 
Artefact removal from EEG is of utmost importance with the gold standard being 
manual scoring. Another method of automated artefact removal is independent 
component analysis (ICA).  
Objective 
1. Investigate the role of conventional and newer methods of EEG analysis as an 
objective and quantitative measure of testing vigilance in patients diagnosed with 
OSA by comparing it with subjectively rated sleepiness, as well as a battery of 
neurobehavioral performance testing. 
2. Validate the use of ICA in a group of patients diagnosed with OSA. 
 
vi 
Methodology 
Retrospective cross-sectional study of untreated OSA patients.  
Results 
ICA and manual artefact removal gave well-correlated interchangeable results in the 
DFA scaling exponent, but not PSA measurements.  
EEG slowing measured by PSA metrics and DFA did not correlate to impaired 
performance during a battery of 14 separate performance tests, as well as AusEd driving 
task in this group.  
Conclusion 
ICA and manual artefact removal can be interchangeably used in extracting DFA 
measurements with confidence. PSA metrics have shown to be highly influenced by 
artefact, therefore, the use of ICA may not be reliable.  
The novel EEG measurement, DFA scaling exponent was superior to that of power 
spectrum measurements in withstanding artefact.  
DFA is complementary to the currently used PSA metrics and will be valuable during 
circumstances of increased artefacts, for example, EEG measurements during a driving 
task. 
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1. INTRODUCTION  
1.1 An overview of obstructive sleep apnoea (OSA) 
1.1.1 Pathophysiology of OSA 
In obstructive sleep apnoea (OSA), the muscles of the upper airway collapse during 
sleep, causing a temporary obstruction. This cuts off the airflow to the lungs for a period 
of time causing a drop in oxygen saturation in the blood. This oxygen desaturation leads 
to an arousal response, causing the patient to wake up and take a breath, abolishing the 
cycle of obstruction. The level of desaturation that needs to occur to cause an arousal, as 
well as the length of the apnoea, varies markedly from one patient to another. However, 
as apnoeas become more frequent and oxygen desaturation becomes more pronounced, 
OSA is considered to be severe.  
For technical purposes, apnoeic events are categorised in two groups according to 
the American Academy of Sleep Medicine Guidelines (1), as listed below: 
1.  Apnoea – A drop in airflow by ≥90% of pre-event baseline using an oro-nasal 
thermal sensor for ≥10 seconds. 
2.  Hypopnea – A drop in the airflow by ≥30% of pre-event baseline using nasal 
pressure for ≥10 seconds in association with either ≥3% arterial oxygen 
desaturation or an arousal. 
There were two main factors that lead to the development of OSA (2) (Appendix Table 
1.1): (i) acquisition of a small upper airway; and (ii) loss of upper airway dilator muscle 
activity. 
A small upper airway could be the result of obesity, upper airway lesions such as 
enlarged tonsils or tumours, or hormonal factors, for example, acromegaly or 
hypothyroidism. 
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A loss of upper airway dilator muscle activity tends to occur due to extrinsic factors 
such as using sedatives and alcohol, as well as intrinsic factors, for example, cerebral 
vascular accidents and Arnold-Chiari malformations. 
1.1.2 OSA epidemiology  
OSA is a common condition. Approximately 2-4% of middle-aged men and 1-2% of 
middle-aged women have clinically significant OSA (3). There is a strong association 
between obesity and the development of OSA (4). This is likely to become more 
pronounced in the coming decades due to the increasing rates of obesity worldwide. 
OSA has an association with age. In children, it is commonest between the ages of two 
and six mainly due to the increased size of adenoids and tonsils during this period (5). 
In adults, OSA becomes more frequent with increasing age. The odds ratio of 
developing OSA doubles with every decade until age 60 (2) . After 60 years of age, 
OSA becomes even more frequent. The prevalence rate in elderly patients has been 
recorded up to 24% (6). With the increase in the elderly population, OSA will become a 
common co-morbid condition in the future (7). There is a familial tendency for 
development of OSA where the risk of developing OSA is doubled if a parent or a 
sibling has OSA (8).  
There is also an ethnic variation to OSA. For example, individuals with Polynesian and 
Chinese ancestry are reported to have a greater likelihood of developing sleep apnoea, 
even when adjusted to the body mass index (BMI) (2). 
1.1.3 Clinical symptoms of OSA 
Patients with OSA can present with a variety of symptoms. Loud snoring, witnessed 
apnoeas and excessive daytime somnolence are the hallmark features of OSA. However, 
not all patients present with these symptoms. There is a marked individual variation in 
symptomatology. It is not uncommon to present with disrupted sleep at night-time, 
lethargy, insomnia or frequent nocturnal urination. OSA could also cause sleep 
fragmentation resulting in parasomnias and confusional arousals. Nocturnal angina and 
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nocturnal arrhythmias have also been linked to OSA. Other daytime symptoms are 
frontal headaches, sore throat, reduced libido and impotence. 
The severity of OSA does not always co-relate well to the symptoms of the patients. 
Some patients may have mild OSA and yet complain of severe daytime functional 
impairment, while other patients present with severe OSA and have minimal daytime 
impairment. Hence, the measurement of daytime impairment has become a challenging 
task (9, 10). 
1.1.4 OSA impact on health  
Patients may have had the OSA for many years before they seek medical attention (11). 
Some patients adjust their lives to cope with the symptoms and most of the time they 
consider their ill-health to be ‘normal’ and are surprised to see how well they felt after 
initiating effective treatment (12). 
Severe OSA is associated with cardiovascular morbidity and mortality (13), and 
hypertension (14). It may also be a risk factor for CVA and myocardial infarction (15). 
Patients with OSA are more likely to have diabetes mellitus and hyperlipidaemia. The 
link between OSA and increased metabolic risk is now well recognised (16).  
Severe OSA may lead to low libido and erectile dysfunction (17). OSA in pregnancy 
may be associated with low birth weight (18). 
The presence of severe OSA was associated with an increase in all-cause mortality. 
Middle-aged men with an Apnoea-Hypopnea Index (AHI) of more than 20 events per 
hour had mortality as high as 20% at five years and 35% at eight years. The cause of 
death ranged from accidents, cerebral vascular accidents, myocardial infarction, cardiac 
arrhythmias or hypertension associated conditions (19). However, this study had 
limitations of being a retrospective and uncontrolled trial. 
More recent data of well controlled long term longitudinal studies have confirmed 
increased cardiovascular mortality in patients with OSA (20). 
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Beyond its impact on an individual, OSA is also an important public health issue. The 
most marked concern from a public health issue is daytime hypersomnolence and 
reduced vigilance in OSA patients, including its effect on others. This reduced 
neurocognitive function not only puts patients at risk, for example, accidents when 
operating heavy machinery, but also puts the individual patient at risk, for example, 
motor vehicle accidents (21).  
1.2 OSA and Vigilance 
1.2.1 OSA and vigilance 
Patients with OSA experience neuropsychological deficits falling broadly into three 
areas of daytime sleepiness: (i) cognitive deficits; (ii) reduced driving competence; and 
(iii) impaired psychosocial well-being (22). Most OSA patients perform poorly 
compared to controls in vigilance and attention tasks such as continuous performance 
testing and driving simulator tests (23). These impairments are thought be a result of 
sleep fragmentation and intermittent nocturnal hypoxia secondary to OSA (24, 25) . 
The risk of motor vehicle accident (MVA) in severe OSA is two to 10 times higher than 
that of the general population (26). A previous meta-analysis of nine observational 
studies examining the MVA of drivers with OSA before and after CPAP treatment 
found a significant reduction in risk with CPAP use (27). The rate of workplace 
accidents is at least doubled in patients with OSA (28). There is a high prevalence of 
minor psychiatric morbidity and reductions in functional and health status among 
patients with OSA (22). 
Although daytime sleepiness is commonly associated with severe OSA, this is not true 
in all cases. Not all patients with OSA develop excessive daytime sleepiness (EDS); the 
severity of OSA is not directly proportional to the EDS in all patients and neither is 
there a consistent relationship between patient-reported EDS and measured tendency to 
sleep by objective testing, for example, maintenance of wakefulness testing (MWT) 
(29).  
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The relationship between reduced daytime performance in OSA and currently available 
and widely used measures of subjective self-reported sleepiness, for example, the 
Epworth Sleepiness Scale (ESS) has been documented to be elusive (30). Hence, there 
is a need for a test to measure impaired function in OSA patients so that we may target 
treatment, evaluate the response to treatment and assess safety at driving or work 
reliably and objectively. 
1.2.2 Existing methods for testing for vigilance 
Daytime performances in OSA patients are conventionally measured using 
questionnaires and performance of tasks to test attention and concentration. The 
standard questionnaires used are the Epworth Sleepiness Scale (ESS) (31), Karolinska 
Sleepiness Scale (KSS) (32), Functional Outcomes of Sleep Questionnaire (FOSQ) (33) 
and Depression and Anxiety Stress State (DASS) (34). The routine performance tests 
that have been used in research previously are driving simulations (23, 35), four choice 
reaction time (36) and finger tapping test (37). 
Two of the most commonly used ‘objective’ testing for vigilance in clinical practice to 
determine somnolence are the Mean Sleep Latency Test (MSLT) and Maintenance of 
Wakefulness (MWT) test (38). 
1.2.3 Problems with existing methods 
Problems with the above questionnaires are that they are self-rated. Some patients with 
OSA may be excessively sleepy while they perceive themselves to be functioning well. 
Hence, they will underscore the severity of their symptoms. Sometimes a fear of 
consequences such as a loss of their driving license pushes patients to under-report 
certain components of the questionnaires. For example, the last question of the ESS: Do 
you feel sleepy during driving? is often marked as ‘0’ by most patients despite all other 
areas of the questionnaire having a disproportionately higher scoring for sleepiness.  
This presents a barrier that is overcome with performance testing. However, the 
problem here is that the severity of daytime performance impairment does not correlate 
well with OSA severity. One individual with severe OSA may perform the driving task 
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well while another with mild OSA may be markedly poor in performance. There is also 
a question as to what extent a driving tests under laboratory circumstances could assess 
real world driving ability such as the risk of MVA. Furthermore, some patients would 
perform better at one test compared to another one. Hence, testing for vigilance is not 
uniformly available and applicable for all patients and does not give a good correlation 
between severity of the disease and symptoms. 
The MSLT and MWT testing are the most objective testing currently used. The MSLT 
is aimed at measuring the physiological tendency to fall asleep in the absence of 
stimulating factors while the MWT measures the ability to stay awake under the same 
conditions during a predefined time duration of 20 or 40 minutes. However, MSLT and 
MWT tests have their own limitations. Both tests are affected by physiological, 
psychological and test protocol variables (38). 
There is a wide variability in both MSLT and MWT sleep latencies in normal 
population which makes interpretation of an individual test result difficult (39). 
It has been argued that ESS may be a better predictor of sleepiness than MSLT/MWT as 
the later measures only one situational sleep propensity while the former provides 
estimate of average sleep tendency (40). 
There is a need for simple objective tests that can easily be administered to find which 
patients are more vulnerable to reduced daytime vigilance.  
1.2.4 Using awake EEG as test for vigilance (qEEG) 
Finding a reliable method of measuring vigilance would be very useful in assessing 
patients who may have impaired daytime performance. This will assist clinical decision-
making when applying appropriate restrictions to driving or operating heavy machinery. 
One possibility is a quantitative analysis of the awake electroencephalogram (qEEG) of 
individuals diagnosed with OSA. EEG consists of different frequency waveforms that 
are generated in the brain. During wakefulness, EEG patterns are different to those of 
sleeping. This difference could be utilised in assessing sleepiness in an individual. 
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During a full diagnostic sleep study, measuring EEG activity is a mandatory component 
of the montage. EEG leads were placed in accordance with an international system of 
10-20 electrode placements (Figure 1.1). Each EEG recording can be divided into small 
sections called ‘epochs’ to help analysis. A conventional sleep study was scored 
visually with 30-second epochs. For this project, the qEEG was analysed in 5-second 
epochs. 
There are many models developed to analyse EEG waveforms. Two methods discussed 
in this project were: 
1. Power Spectral Analysis (PSA) 
2. De-trended Fluctuation Analysis (DFA): Novel method of EEG analysis 
1.2.5 Power spectral analysis of qEEG and its use in sleep disorders 
Each 5-second epoch comprises of different EEG frequencies. Arbitrarily these 
frequencies are classified into bands of beta, alpha, theta and delta frequency (Table 
1.1). 
Table 1.1 EEG waveforms and frequencies 
EEG waveform Frequency Hz Most prominently occurs in 
Beta 12-25 Awake eyes open 
Alpha 8-12 Awake eyes closed 
Theta 4-8 Awake slightly drowsy (Eyes open or closed) 
Delta 0.5-4 Very drowsy (Eyes Open or Closed) 
 
In each 5-second epoch, there would be a different density in each of these waveforms. 
The relative power of each individual waveform can be calculated to obtain an objective 
measure of what waveform predominates. For example, the delta power density of a 
given epoch would be the absolute power of the delta frequency range (0.5-4Hz) 
divided by the sum of absolute powers in delta, theta, alpha and beta (0.5-25 Hz) 
frequency ranges. 
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Delta waves are low frequency larger waves that occur during periods of drowsiness 
when awake, as well as being the predominant waveform during slow wave sleep. 
Hence, higher delta power during awake periods should theoretically indicate increased 
drowsiness in an individual. Theta waves are not as large as delta waves and have a 
higher frequency than delta waves. During wakefulness, a higher amount of theta and 
delta power reflects increased drowsiness. 
Alpha waves are the usual waveform that occurs during resting wakefulness when the 
eyes are closed. However, if alpha waves occur during wakefulness when the eyes are 
open, this may reflect increased drowsiness as well.  
Beta waves are the usual waveform frequency occurring during the restful awake state 
when the eyes are open. 
Use of power spectral analysis (PSA) in sleep disorders 
PSA was used to assess sleep-deprived healthy individuals. In healthy individuals who 
were subjected to 40 hours of extended wakefulness, the theta/alpha density seemed to 
progressively increase. Furthermore, there was a proportional increase in their self-rated 
fatigue score (41). This increase of PSA in low frequency (delta, theta) bands was 
shown again in extended wakefulness of 24 hours in both OSA patients and the healthy 
controls (42). However, the OSA group tended to underestimate their subjective 
sleepiness when both groups were assessed using the KSS (42). 
In OSA patients, EEG slowing (higher ratio of delta and theta power to alpha and beta 
power) was observed in both wakefulness and REM sleep. During wakefulness all 
cortical areas had shown EEG slowing. This explains the reduced functional capacity 
attached to different cortical areas observed in OSA patients, and shows that the effect 
is not limited to the frontal area alone as sometimes speculated (43). 
The same group had looked at whether initiating Continuous Positive Airway Pressure 
(CPAP) treatment for OSA patients would correct this EEG slowing. Following six 
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months of treatment with CPAP, the EEG slowing was corrected in the frontal and 
central cortical regions during REM sleep as well as wakefulness (44). 
Another study shows that when OSA patients underwent treatment with CPAP for three 
months and then were exposed to a sustained awake period of 24 hours, they showed 
reduced theta power compared to pre-CPAP treatment (45). 
EEG slowing seems to be more pronounced with age, as shown when comparing 
patients aged over 50 years, to less than 50 (46). 
1.2.6 Novel method of EEG analysis: De-trended fluctuation analysis 
A newer method of analysing EEG is called de-trended fluctuation analysis (DFA), 
which is a method used to analyse the randomness of an event occurring. This method 
looks at fluctuations in EEG as a function of time after removing artefacts (47). DFA 
provides a single value called a scaling exponent (SE). The scaling exponent increases 
during transition from wake to sleep, continues to increase with deeper stages of non-
rapid eye movement sleep (NREM) and correlates with traditional PSA metrics (47). 
Recently published data from our group that analysed resting awake EEG data at 
baseline and after 40 hours of sustained wakefulness by using DFA measurements 
found that the higher the scaling exponent recorded at baseline and while the eyes were 
open, correlated well with impaired driving performance after 24 hours of wakefulness 
in OSA patients. This baseline DFA measurement gives information as to how the 
subject would perform when they are sleep deprived. Subjects with higher DFA SE at 
baseline showed increased impairment of driving ability if subjected to sleep 
deprivation. Furthermore, the scaling exponent had positive correlation to the delta 
power (increased sleepiness) in PSA and negative correlation to beta power (increased 
alertness) (48). 
1.2.7 Use of DFA in non-sleep disorders 
In anaesthesia, DFA had been used to measure the depth of anaesthesia. It was used to 
measure the difference between the awake, sedated and anesthetised states as a non-
invasive methodology allowing real-time implementation (49).  
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1.2.8 Use of DFA in sleep disorders 
The use of DFA has been looked at in narcolepsy patients. The overnight sleep study of 
10 narcoleptic patients when compared to eight healthy controls showed that there was a 
higher DFA scaling exponent noted during deep sleep stages in narcoleptic patients 
compared with the controls, suggesting a potential application of DFA in diagnosing 
narcolepsy (47).  
Possible use of DFA in OSA patients to assess vigilance 
Preliminary work suggests that DFA of the qEEG recorded at rest may correlate with 
performance on a simulated driving task in patients with OSA. However, this is after 24 
hours of extended wakefulness (48). These findings need to be confirmed in larger 
groups of patients.  
The studies are sparse on the use of DFA in subjects with OSA to assess vigilance in 
non-sleep deprived conditions.  
1.2.9 Advantages of using DFA in place of PSA 
The DFA scaling exponent has some advantages over the power spectral method of 
EEG analysis.  
1. The limitation of PSA is that it assumes the EEG to be linear and stationary, 
which is not accurate (50). 
2. The scaling exponent is the single measure that is extracted from the DFA 
method. This is in place of the four different waveforms explained earlier in the 
power spectral analysis. The frequency bands of each of these PSA waveforms 
are not strictly defined and sometimes have an overlap. For example, Beta 
frequency, in some instances, is defined as 12-25 Hz frequency and at other 
times divided into sigma frequency 12-15Hz and beta 16-25Hz. 
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3. The DFA scaling exponent would be more robust at withstanding artefacts like 
muscle movements and eye blinking that changes the waveforms in PSA. 
If the DFA scaling exponent was found to have a good correlation to vigilance testing 
and performance tasks in patients with OSA, this would be a single metric appropriate 
for non-linear data and more robust to ‘noise’. As with the PSA method, DFA also 
requires a larger set of data to be give a more accurate result (50). Hence, this would be 
a valuable method in analysing the overnight PSG with a large amount of EEG data. 
1.3 Introduction to artefact removal in EEG 
To analyse an EEG accurately, the signal should be as clean as possible to represent 
waves that originate from the cerebral cortex. This is never easy as physiological signals 
such as muscle movements, eye blinking and heart beat may be superimposed on the 
EEG. There could also be artefacts due to equipment interference. Hence, removing 
artefacts or ‘noise’ is very important to get a clean signal for analysis. This can be done 
in two ways: (i) either manually removing the epochs that have artefacts; or (ii) using an 
automated method to identify epochs with artefacts. 
1.3.1 Manual artefact removal 
This is considered the ‘gold standard’ for artefact removal. The conventional method of 
artefact removal is done by an individual trained in this task, for example, a certified 
sleep technologist, and excludes the epochs that have eye blinking or muscle 
movements. While this is the gold standard method, it is time-consuming because each 
5-second epoch needs to be examined. In terms of analysing lengthy timeframes, this is 
very tedious and not practical. The other disadvantage is that when manual artefact 
removal is used, ‘noisy’ epochs have to be excluded completely, thereby reducing the 
power of the recordings as fewer epochs can be included in the analysis. Furthermore, 
when epochs are excluded, valuable information about the artefacts will be lost and a 
full representation of the EEG activity during the examined time period is not obtained. 
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1.3.2 Independent Component Analysis (ICA) 
Several methods of artefact removal from EEG recordings have been published before 
(50, 51) One such method of automated artefact removal is independent component 
analysis (ICA). Most of the work in ICA relates to epileptiform activity monitoring, as 
it is a complex task separating ictal waveforms from artefacts for accurate interpretation 
of the seizure activity (53). In ICA, a reference signal is used for an artefact (e.g. eye 
movement extracted from EOG channel), which is then subtracted from the EEG after 
scaling it by an appropriate factor determined by regression in the time or frequency 
domains (53).  
Figure 1.1 illustrates the mechanism of artefact removal. Section A demonstrates a 
seizure contaminated by marked ocular activity on channels Fp1-F7, F7-T3, Fp2-F8, 
F8-T4, Fp1-F9, and Fp2-F10. To a lesser degree, there is muscle activity in channels 
Fp1-F7, F7-T3, and Fp1-F9.  
In section B, the ICA is applied and most of the artefacts have been removed, 
preserving the underlying EEG activity (53). 
 
Figure 1.1 ICA artefact removal method demonstrated in an ictal EEG 
 
Our research group internally developed a program incorporating ICA to automatically 
‘correct’ the EOG artefacts in the EEG components without excluding the epochs from 
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analysis. We had validated this artefact removal method previously (48). The EEG data 
of 17 individual healthy controls (each patient had five recordings consisting of 7.5 
minutes of qEEG data) comprising of 85 EEG recording in total were analysed for 
artefact using three methods: (i) ICA; (ii) manual scoring; and (iii) raw data without 
artefact removal.  
When values of DFA scaling exponent obtained by the manual scoring and ICA were 
compared to driving performance, the results did not show any significant difference 
between the two methods (48). For example, AusEd steering deviation ICA: r = 0.62 
and manual: r = 0.61. 
Hence, using the ICA improved the power of the data as more data was preserved and 
was also less labour intensive and time efficient.  
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2. OBJECTIVE 
The aims of this project are to: 
1. Investigate the role of conventional and newer methods of EEG analysis as an 
objective and quantitative measure of testing vigilance in patients diagnosed with 
OSA by comparing it with subjectively rated sleepiness, as well as a battery of 
neurobehavioral performance testing. 
2. Validate the use of ICA in a group of patients diagnosed with OSA.  
If validated, these techniques will enable the researcher to accurately quantify reduced 
vigilance in OSA patients and find characteristics that determine the patients who are at 
higher risk of drowsiness by using EEG recordings routinely collected as part of a 
polysomnogram used in the clinical evaluation of sleep apnoea. 
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3. METHODOLOGY  
3.1 Study design 
The study design is a retrospective cross-sectional observational study of untreated OSA 
patients. 
3.1.1 Ethics approval 
The Sydney South West Area Health Services Human Research Ethics Committee 
(RAPH zone) granted the ethics approval for the initial project titled ‘Neurobiological 
effects of sleep apnoea and sleepiness’ Protocol No. X06-0299 (Appendix 4). The 
research student was included as an associate investigator for this project to enable 
student to extract the data from this study to use in this project.  
The original study from which data was extracted was registered with the Australian 
Clinical Trials Registry as an observational study (ACTRN 012605000089639). 
3.1.2 Participants 
Previously collected data on patients with untreated OSA by our research group as per 
Protocol No. X06-0299 was used to validate this novel methodology.  
The participants were adults aged 18-75, with diagnosed or suspected OSA but not 
commenced on treatment for OSA with reasonable fluency in written and spoken 
English enabling them to perform neurocognitive tasks satisfactorily. 
Participants with sleep disorders other than OSA were excluded. Other exclusion 
criteria were epilepsy, previous stroke, significant uncontrolled co-morbidities like 
cardiac failure, respiratory failure or malignancy and regular use of medications known 
to affect sleep architecture or EEG (e.g. antidepressants and antipsychotic drugs). 
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3.1.3 Protocol and measurements  
The protocol explained here is that of the initial study (Clinical Trials Registry No. 
ACTRN 012605000089639) from which the student had extracted data for this project. 
Screening and recruitment 
Potential participants who were clinically suspected of OSA and booked for a 
diagnostic sleep study were contacted prior to the diagnostic study. The study rationale 
and procedure were explained and eligibility was determined. Those verbally 
consenting participants were requested to attend the overnight polysomnography during 
the usual time. Bookings were made at the Brain Resource Company for an 
neurocognitive functioning appointment. 
Sleep laboratory visit 
Testing was performed prior to the diagnostic sleep study and on the morning after the 
sleep study. Participants were requested to refrain from caffeine from 0900h of the date 
of the sleep study until all investigations were completed. They arrived at the sleep 
laboratory at 1630h, which is the usual requested time of arrival for preparing the 
overnight study. The study procedure was explained, written consent was obtained, and 
testing schedules were explained. External sensors used for overnight polysomnography 
were attached to the subject, including seven extra EEG leads. Additional leads were 
placed in the Fz, Cz, Pz and Oz regions, left lateral, right lateral and right supra-ocular 
electrooculogram (EOG). 
After checking for signal accuracy, the waking EEG recording was performed for the 
above described five-minute duration. This was followed by the Tower of London task 
(3 minutes practice run and 8-12 minutes of test) and the AusEd driving task (5 minutes 
practice and 30 minutes of testing). After testing, dinner was provided (as per routine 
sleep unit practice). The participants were then administered questionnaires. The 
overnight polysomnography recording commenced at 2130h and terminated at 0600h. 
After breakfast, the participants were asked to attend neurocognitive testing at the Brain 
Resource Company (0900 to 1200h). 
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3.1.4 Statistical analysis 
Data was analysed using SPSS statistics 21.0 for Mac (IBM SPSS, Somers, NY, USA). 
Statistical support was given by Ms Anne-Sophie Valliard (biostatistician) from Sydney 
University and Dr Keith Wong, Staff Specialist from Royal Prince Alfred Hospital, 
(Camperdown NSW). 
3.2 Measurements of vigilance 
3.2.1  Diagnostic polysomnography  
Polysomnography was performed at the Sleep Unit of Royal Prince Alfred Hospital 
using Compumedics E series acquisition hardware. The setup was similar to a routine 
diagnostic sleep study. EEG leads were placed according to the international 10-20 
specifications (Figure 3.1). Seven additional leads in the Fz, Cz, Pz and Oz regions, left 
lateral, right lateral, right supra-ocular electrooculogram (EOG) were placed. All EEG 
leads were sampled at a rate of 256Hz, with a high pass filter placed at 0.3Hz and low 
pass filter at 50Hz. Sleep staging and manual scoring of arousal and respiratory events 
were performed using standard criteria (1). 
 
Figure 3.1 International 10-20 system of electrode placement 
 
F= Frontal Lobe 
T= Temporal Lobe 
C=Central Lobe 
p=p=Parietal Lobe 
O=Occipital Lobe 
Z= electrode placed in the midline 
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3.2.2 Awake EEG (qEEG) 
Awake EEG is acquired prior to commencing the sleep study. Patients would be 
attached to EEG scalp electrodes as above in preparation for their overnight study. The 
signal accuracy is checked when the patient is awake. All EEG acquisitions at the sleep 
laboratory used the same Compumedics E series hardware that was used for the 
polysomnogram. A five-minute resting awake EEG was performed using the above-
described leads. This component of awake EEG measurement is named the Karolinska 
Drowsiness Test (KDT), and it may be used as a test to measure vigilance in patients. 
During the KDT, patients were required to sit upright in bed in a quiet room with 
ambient indoor lighting. They were requested to fix their gaze on a dot placed two to 
three metres away at eye level on a wall, staying relaxed but awake. The signal integrity 
was checked before recording commenced. After two minutes, the subject was 
instructed to close their eyes. The recording was terminated after another two minutes.  
3.2.3 Self rating questionnaires  
Questionnaires commonly used to assess vigilance were used to assess the impact of 
sleepiness. 
Epworth Sleepiness Score (ESS) 
The ESS is an eight scenario self-rated questionnaire used extensively in sleep research 
and clinical practice. It has been validated in healthy volunteers and in sleep apnoea 
(31). In each given scenario, the subject is asked to indicate their likelihood of falling 
asleep. The response for an individual item being a score of 0 indicates no chance of 
dozing, up to a score of 3 which indicates a high chance of dozing. The total score 
would be out of 24 (Appendix Table 2).  
Karolinska Sleepiness Scale (KSS) 
The KSS is a single item measurement of sleepiness in an individual at that moment. 
There are nine possible responses ranging from 1 indicating ‘very alert’ to 9 ‘very 
sleepy; great effort to keep awake; fighting sleep (Appendix Table 3). This scale is used 
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to indicate an individual’s current state of sleepiness as opposed to a ‘trait’ of 
sleepiness. 
The KSS has been validated against performance and EEG variables in a small group of 
healthy individuals (n=16). The variables of median reaction times and the number of 
lapses in the psychomotor vigilance task, as well as alpha and theta power density have 
shown significant increase with the increase of the KSS score (32). 
Depression Anxiety Stress Scale (DASS) 
A questionnaire on depression and anxiety was included because both these conditions 
can make a subject feel sleepy, resulting in mood disorders becoming a compounding 
factor. At the same time, mood disorders can occur as a secondary consequence of 
OSA. The depression and anxiety score is a 21-item questionnaire (Appendix Table 4) 
to self-rate depression, anxiety and stress (a shorter version of the 42-item full DASS 
questionnaire). The DASS is a widely used instrument in research (34). Subjects are 
asked to use a 4-point severity/frequency scale to rate the experience of each state over 
the past week. 
The scale has questions relating to three components: (i) depression; (ii) anxiety; and 
(iii) stress. Each sub-class has seven questions to rate that particular mood. Scores are 
calculated by adding the ratings from items belonging to each of the three subscales: (i) 
depression, items 3,5,10,13,16,17,21; (ii) anxiety, items 2,4,7,9,15,19; and (iii) stress, 
items 1,6,8,11,12,14,18. 
The answers were added and multiplied by two to give a final score that was 
comparable to the 42 question standard DASS questionnaire. 
Functional Outcome of Sleep Questionnaire (FOSQ) 
The functional outcomes of the FOSQ is a 30-item self-reported scale that explores the 
extent to which sleepiness affects five aspects of daily living (33) (Appendix Table 5).  
1. General productivity (items 11-4 and 8-11) 
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2. Social outcome (items 12 and 13) 
3. Activity level (items 5, 14-16, 22-26) 
4. Vigilance (items 6-7, 17-21) 
5. Intimacy and sexual activities (items 27-30) 
The test requested subjects to mark the degree of difficulty experienced in performing 
each activity. The response was given a mark from 1 to 4 with smaller values 
representing greater difficulty. If participants indicated they did not engage in that 
activity, it was marked as ‘missing’. The arithmetic mean of the non-missing responses 
formed the subscale results. 
3.2.4 Performance testing  
AusEd driving simulator 
The AusEd driving simulator assesses multiple performance areas, including attention, 
concentration and executive functioning. The AusEd driving task (Woolock Institute of 
Medical Research, Sydney, Australia) (35) is a PC-based task simulating driving on a 
country road at night. It is sensitive to performance decrement from driver fatigue in the 
laboratory setting, potentially making it useful as a laboratory or office-based test for 
driver fatigue risk management. 
The test was performed after satisfactory understanding of the instructions and controls 
were achieved on a 5-minute practice run. The practice run was supervised by the 
researcher who repeated the practice task if needed. 
The actual test was 30 minutes in duration and comprised of alternating 2-minute 
winding and 5-minute straight periods. Participants were asked to drive in the centre of 
the left-hand lane. They were requested to maintain a speed between 60-80 km/h. A 
speedometer was available on the top left-hand corner of the display. Ten trucks were 
presented at random intervals during the task. As soon as trucks appeared, the 
participant was requested to remove his/her foot from the accelerator pedal and depress 
the brake pedal, followed by returning the foot to the accelerator panel and continue 
driving. 
21 
The measurements taken during this task were: 
1. Steering deviation (stdvm) 
2. Speed deviation (spdev) 
3. Mean reaction time to braking (rtmn) 
4. Number of crashes (crash) 
Data from the first six minutes were excluded from analysis to reduce the effects of 
acclimatization to the task. 
Previously published data demonstrated that patients with OSA had more lane 
variability, speed variability, steering rate variability and a higher number of crash 
frequency over a 60-minute driving task compared to the control (55). 
The AusEd simulator has shown to be a sensitive marker in measuring mean reaction 
time and speed deviation following 30 hours of extended sleep deprivation in OSA and 
healthy individuals (56). In another study, the AusEd task was used for 70 minutes and 
a small dose of alcohol was added to give a mean blood alcohol concentration of 
0.037g/dl, in addition to one night’s sleep restriction of five hours in bed. The result 
indicated a worsening of the steering deviation and mean reaction time to break when 
compared with sleep restriction alone (57).  
Tower of London Task (Executive functioning) 
The Tower of London task was used to assess executive functioning. It has been shown 
to assess executive planning in healthy elementary students and young adults (58). The 
task involves moving coloured balls stacked on pegs into a goal position by using a 
minimal number of moves (Figure 3.2). 
This test has not been used to assess vigilance in OSA patients in past research. 
However, functional MRI had shown that when comparing a hard condition relative to 
an easy task (difficulty based on the number of moves required to solve a problem) in a 
healthy adult, there was prominent frontal lobe activation (Figure 3.3). This is a region 
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thought to be vulnerable to EEG slowing during wakefulness and sleep in OSA patients 
(44). 
 
Figure 3.2 Tower of London Task 
 
A computerised version of this task was administered (Colorado assessment tests, 
version 1.2, Colorado Springs, Colorado USA). The software automated the process of 
administering the test and produced written and spoken instructions at the start of the 
testing session. A brief practice session lasting three minutes was given prior to the 
actual test, which lasted 8-12 minutes. The subject had to move the coloured balls 
between pegs by using a computer mouse. Trials from the practice test were not 
repeated during the actual test, however, computer software automated the scoring. 
Measurements observed in this task were: 
1. Total number of moves, above the minimum required to solve the problem 
(t.excess) 
2. Average time taken per trial to solve the problem (t.avtrial) 
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Figure 3.3 Functional MRI enhancement in the frontal lobe while performing difficult 
tower of London task (Roth et al. (2006) Brain Imaging Laboratory, 
Dartmouth Medical School 
 
Four choice reaction time test (Attention) 
This test assesses reaction time and is a measure of attention. There are four circles on 
the computer screen and one would randomly light up. The subject is instructed to touch 
that circle as quickly as possible. This test has been used in OSA patients. In a test of 
90-minute duration, random appearance of a choice every 20-40 seconds showed that 
the reaction time was linearly correlated to the vigilance state (36). The measurement 
taken was the average speed of response (Ch_avrt). 
Visual timing (Attention) 
This task determines visual attention and subjective sense of time intervals. When a 
circle appears on the screen for 1-12 seconds, the participant is requested to indicate 
how long the circle was visible. The time estimation task has been associated with 
changes in frontal brain of healthy aging adults (59). 
The measurement from this task was the value of the average difference between the 
(actual lengths of the stimulus – subjects estimate) weighted by the actual length of the 
stimulus (t_prbias). 
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Sustained attention task (Attention) 
A series of letters (e.g. B, C, D and G) are presented for 200ms each. The participant is 
requested to press the button if the same letter appears twice in a row. 
Measurements from this task were: 
1. Number of incorrect responses, or false positives (Wmfp) 
2. Number of targets the subject did not respond to, or false negatives (wmfn) 
Switching of attention (Attention and executive functioning) 
This test has two components: (i) Part A: a participant is requested to touch a sequence 
of 25 numbers scattered across the screen in ascending order (Figure 3.4) (60); and (ii) 
Part B: the subject touches alternating numbers 1-13 and letters (A-L). The second part 
is dealing with executive functioning. 
 
Figure 3.4 Trail-marking test – Part A 
 
Measurements from these tests were: 
1. Time to complete test A successfully (Swoadur 1) 
2. Time to complete test B successfully (Swoadur 2) 
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Finger tapping test (Manual dexterity/attention) 
The manual dexterity test requires the participant to tap a circle with the index finger as 
many times as possible within 30 seconds. The task is performed using both hands. 
Slowing of the tapping has been associated with sleep onset drowsiness (37). 
Measurements from this task were: 
1. Number of taps over 30 seconds – dominant hand (tapdomn) 
2. Number of taps over 30 seconds – non-dominant hand (tapndmn) 
Memory recall and recognition (Memory) 
This is a test to determine delayed memory recall and memory recognition. A list of 12 
words is read to the subject four times. The participant is asked to recall the words after 
each reading (recall trials 1-4). A second distracter list is presented that has to be 
memorised. Twenty minutes later, the subject is asked to recall the original list (memory 
recall). In the second part of the test, the participant is shown a list of words and asked 
if they belonged to the original set of words (memory recognition). 
Measurements from the memory recall and recognition tasks were: 
1. Total number of words recalled over trials 1-4 (memtot14) 
2. Number of words recalled after the trial at 25 minutes (memrec7) 
3. Words correctly recognised as from the original list (memrecco) 
Digit span (Memory) 
This is a test of memory. After a hearing sequence ranging from 3 to 9 digits, the 
participant enters the numbers on a numeric keypad in the order they were presented. 
(Forward digit span). The reverse digit span is when the subject is asked to enter the 
digits in the reverse order of presentation (61). 
Measurements taken during this test were: 
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1. Forward digit span – Longest sequence correctly completed (digitot) 
2. Backward digit span – Longest sequence correctly completed (rdigitot) 
Span of visual memory (Memory) 
This task assesses the working memory. This is also known as the modified Corsi 
block-tapping test (62). Up to nine identical squares light up on the display in a random 
fashion. The participant has to tap the sequence in the order they lit up once they hear a 
tone. The sequence starts out simply, usually using two blocks, but becomes more 
complex until the subject’s performance suffers (Figure 3.5). 
The measurement from this test is the longest sequence correctly completed (Spvm) 
 
Figure 3.5 Corsi block tapping test  
Note: Yellow is the current block in sequence. 
 
Verbal interference (Verbal fluency) 
Also referred to as the Stroop test (63), this test consists of two parts. In the first part, a 
coloured word (red, yellow, green or blue) appears on the screen (Figure 3.6). The 
participant is requested to indicate the colour the word is spelling out by pressing a 
button allocated to the four colours mentioned. Then the participant is requested to 
indicate the colour of that word . The words and colours are always incongruent. 
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Measurements in these tests are: 
1. Stroop (text) – number of words correctly identified (Vi_scol) 
2. Stroop (colour) – number of colours correctly identified (Vi_sco2) 
RED 
YELLOW 
GREEN 
BLUE 
 
Figure 3.6 Stroop test – incongruent text and colours 
 
Word generation FAS test (Verbal fluency) 
Also known as the controlled oral word association test (FAS test), this test requests the 
participant to recall as many words as possible beginning with each of the letters F, A 
and S. One minute is allowed for each letter. Responses are recorded and manually 
scored. 
The measurement taken from this test is the FAS score – Number of words recalled 
across the three letters (fas). 
Word generation animal test (Verbal fluency) 
In this task, the participant is requested to recall the names of as many animals as they 
can starting with a selected letter. The time allocated for this task is one minute. The 
measurement taken was the number of words recalled (animals). 
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Spot the real world (Intelligence) 
The participant is presented with two pairs of words (64): one has a true meaning; and 
(ii) the other is a non-word. The measurement of this task is the number of real words 
recognised (spotscor). 
Maze task (Executive functioning) 
The task combines memory and planning with self-monitoring. The participant is 
required to remember a hidden path through a maze. The task is completed either when 
the participant traces the same path twice in a row successfully or when the time limit of 
eight minutes is reached.  
Measurements from this task are: 
1. The number of trials completed before the end of the task. (mazetrls) 
1. The total number of off-path moves (mazeerr) 
3.3 Comparing EEG artefact removal methods (ICA vs manual 
scoring)  
3.3.1 EEG preparation for analysis 
Each individual awake EEG recorded in Compumedics E series software was extracted 
into a universal viewing program called EDF viewer that was able to run the analysis 
using the software program developed by our group (47). Each 5-minute awake EEG 
segment would have a 2.5 minute ‘eyes open’ segment followed by a 2.5 minute ‘eyes 
closed’ segment. During the awake EEG recording, procedural instructions were given 
by the technician to the participant, to initiate each ‘eyes open’ and ‘eyes closed’ 
component. Consequently, 30 seconds at the beginning of each 2.5-minute segment was 
discarded. Hence, the final EEG data would have two minutes of eyes open (EO) and 
two minutes of eyes closed (EC) segments. 
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Eighty-three awake EEG recordings were extracted from the data set, each consisting of 
two minutes of ‘eyes open’ (EO) and two minutes of ‘eyes closed’ (EC) resting awake 
EEG extracted to a EDF viewer. For each recording, the Cz channel was selected for 
analysis. It was the preferred instrument because it was a midline channel that would 
not have been influenced by the hand dominance of the patient. All 83 awake EEG 
recordings were then manually screened in 5-second epochs to look at signal integrity 
and artefacts.  
3.3.2 Manual method of EEG artefact removal  
As mentioned above, artefact removal is of paramount importance for obtaining a clean 
signal in the awake EEG. This is especially important when EEG data are being used to 
correlate the testing of vigilance to assess drowsiness. Muscle movements and eye 
blinking can generate large low frequency waves that can be interpreted as delta waves 
if not correctly excluded. 
Manual removal of artefacts is the gold standard. However, adequate training and 
pattern recognition is required to do this accurately. The manual artefact removal is time 
consuming and labour intensive. In this project data of 83 recordings of 4-minute 
duration for each recording, involving 3984 epochs in total was analysed for artefact by 
the student. The student was trained in EEG analysis for artefact removal prior to 
commencement of the study. 
The student was requested to perform manual scoring of 20 randomly selected patient 
qEEG data from the 83 patient records to assess the adequacy of training prior to 
analysis of the entire data set. These EEG scoring was then discussed with the student in 
a group meeting by Dr Jon Wong Kim and Ms. Angela Denotti for agreement of 
marking of the ‘noisy’ epochs and discussion regarding ICA and manual scoring. The 
student was found to be scoring artefacts at the expected level. 
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Figure 3.7 A screen shot of a 5-second epoch with marked artefacts (‘noisy’ epoch 
excluded during manual scoring) 
 
 
Figure 3.8 A screen shot of a 5-second epoch with minimal artefacts (‘clean epoch’ 
included during manual scoring) 
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Figure 3.9 A screen shot of 5 second ‘clean’ epoch without artefact 
 
 
Figure 3.10 A screen shot of the same 5 second epoch analysed by ICA (marked in 
green), demonstrating overlapping waveform without corrections 
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Figure 3.11 A screen shot of 5-second epoch showing a ‘noisy’ epoch with an eye blink 
artifact 
 
 
Figure 3.12 A screen shot of the same 5 second epoch with ICA correction marked in 
green 
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During manual artefact removal each of the epochs are marked as ‘noisy’ (has artefact) 
(Figure 3.7) or clean (no artefacts) (Figure 3.8) and the software has the capability to 
store these changes. Once marking was completed for all four minutes, the manual 
artefact removal can be saved in the same patient folder. The epochs marked as ‘noisy’ 
were excluded from the analysis. Following this the analysis for both DFA scaling 
exponent and PSA can be run on the saved manual data by using the software developed 
by our group. 
3.3.3 ICA for artefact removal 
The above process is made much simpler by using the automated ICA artefact removal 
method. Once the 4-minute qEEG was selected from a participant, then the software 
allows the operator to select ICA option for artefact removal (instead of manual), and 
then directly obtains the analysis for PSA and DFA measurements.  
This ICA option automatically analyses each 5-second epoch and the noisy epochs 
identified, however they are not excluded. Instead they are normalised by removing the 
eye blink artefacts. Artefacts due to heart rate or other muscle movements were not 
removed by this method. 
3.3.4 Analysing the EEG data to obtain PSA and DFA measurements by 
using both artefact removal methods 
Once artefacts have been removed the clean EEG segments was analysed for PSA and 
DFA measurements. This gives two sets of results; one for manual artefact removal and 
one for the ICA. During the PSA analysis, the results are displayed as individual 
absolute values of delta, theta, alpha and beta frequencies for each five seconds. Each of 
these waveforms are then individually summed across the 48 epochs of each patient to 
give final values for the previously mentioned delta, theta, alpha and beta for each of the 
eyes open (24 epochs) and eyes closed (24 epochs) segments.  
DFA analysis however gives only one parameter called the scaling exponent for each 5-
second epoch. These values of the DFA SE across the 48 epochs for each patient are 
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then summed to give the total scaling exponent during eyes open (24 epochs) and eyes 
closed (24 epochs) state. 
During this study, EEG slowing was measured in three ways: 
1. Using PSA ratio of delta power and theta power to alpha power and beta power, 
this was a ratio of slow frequencies: delta and theta (indicating sleepiness) to the 
faster frequencies: alpha and beta (indicating alertness). It was selected as a 
global index for EEG slowing. A higher value indicates reduced alertness. A 
study done by Morrison et al. (43) involving 21 OSA patients compared to 10 
normal controls demonstrated increased EEG slowing using this method during 
REM sleep in frontal, central and parietal regions while EEG slowing during 46 
wakefulness occurred in all cortical regions. This may explain the wider range of 
performance impairment seen in OSA patients and not limited to executive 
functioning. 
2. Using PSA ratio of theta to alpha power waves (measuring the ratio between 
more drowsy waves to the more alert waves), a higher value indicated reduced 
alertness. A study by Greneche et al. (41) demonstrated increased theta/alpha 
density when nine healthy women were subjected to 40 hours of extended 
wakefulness. There was a correlated increase in the self-rated fatigue score as 
well. 
3. Using DFA scaling exponent (higher the value of scaling exponent, more 
sleepier the subject), Rozeraio et al. (48) demonstrated higher DFA scaling 
exponent and higher delta power during wakefulness in OSA patients than 
controls. The baseline DFA scaling exponent was found to be a marker for 
impaired driving performance after 24 hours of extended wakefulness in patients 
with OSA. 
Each EEG slowing parameters were measured during eyes open and eyes closed state. 
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During the statistical analysis of multiple correlation testing for EEG slowing and 
performance testing there is a one in 20 chance of a false positive result. The results 
could also be falsely positive due to outliers in the given sample. Hence once the co-
relation tests are carried out they will then be plotted in a scatter plot to assess the 
validity of the results (65). 
3.4 Statistical methods used to compare the two 
methodologies of artifact removal (Manual vs ICA) 
A literature review identified several statistical methods that measure the agreement 
between two measurements, as is the case with this study. One single statistical method 
was not superior or accurate in drawing conclusions, hence five statistical methods 
namely: (i) student t-tests; (ii) effect size measurement; (iii) Bland-Altman plots; (iv) 
Pearson’s correlation coefficient; and (iv) intra-class correlation coefficient 
measurement were used to draw a combined inference. 
3.4.1 Student’s t-test 
The paired sample student’s t-test was used to ascertain whether their is a difference in 
the sample mean when using ICA and manual artifact removal method in each of the 
PSA wave densities and DFA scaling exponent measurements during EO and EC states. 
A P value <0.05 was considered to be the statistical significant level. 
3.4.2 Effect size 
Effect size was used to measure the clinical significance of the difference noted between 
two measurements as statistical significance does not automatically transform to clinical 
significance. This was measured by dividing the mean difference between the 2 groups 
of each EEG measurement by the standard deviation of the manually extracted data of 
the same measurement, e.g. effect size of delta power = mean difference of delta power 
(i-n)/SD of delta power(n). 
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3.4.3 Bland-Altman plots 
To further clarify the scatter of the difference between the measurements of the two 
artefact removal methods, Bland-Altman plots (B&A plots) were used. The mean of the 
two measurement methods were to be plotted against the standard deviation of the 
difference between the two methods to decide if the limits of agreement are narrow or 
wide, e.g. Bland-Altman plot for delta power would comprise of the X axis (delta power 
i+n/2) plotted against the Y axis; the mean difference of the two values (delta power 
i-n). 
3.4.4 Pearson’s correlation coefficient 
Person’s co-relation was calculated to find out the strength of the association between 
the two methodologies of artifact removal. The results are then explored further for 
validity and outliers by use of scatter plots. 
3.4.5 Intra-class correlation coefficient for agreement 
To test the absolute agreement between the two methods of artifact removal, intra-class 
correlation coefficient was performed. 
3.5 Comparing the EEG measurements (PSA and DFA) with 
vigilance testing 
There is limited data on using PSA power spectrum EEG slowing to assess vigilance. 
Using DFA scaling exponent our group had recently published data on driving 
performance in patients with OSA after extended wakefulness with encouraging results. 
The use of DFA is novel and data is unavailable on vigilance testing in non-sleep 
deprived OSA patients.  
In the current project, four main domains were included for vigilance testing: (i) 
attention and concentration; (ii) memory; (iii) verbal fluency; and (iv) executive 
function. 
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The above vigilance testing elements were compared against PSA and DFA parameters 
to determine whether there was a good relationship that enabled awake EEG measures 
to be used as an objective method of assessing vigilance. The DFA and PSA 
measurements were then compared against each other to assess if they gave comparable 
results. 
3.6 Assessing the relationship between PSA and DFA in 
awake EEG 
Previous studies done by our group showed that the conventional EEG PSA measures 
significantly correlated with DFA scaling exponent in both eyes open and eyes closed 
states. The DFA scaling exponent was positively correlated to delta power density (eyes 
open/eyes closed r=0.75, p<0.0001/r=0.86, p<0.0001) and negatively correlated to alpha 
power density (r=-0.56, p<0.0001/r=-0.73, p<0.0001) (40). This association would be 
explored further using this data set. 
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4. RESULTS 
4.1 Participant Demographics 
Eighty-three study participants completed satisfactory awake EEG testing prior to the 
overnight sleep study. The majority of the patients were male 67 (81%). Mean age was 
45 years (SD +/-11 years). The mean BMI was 32kg/m2. (SD +/-5.5kg/m2). The mean 
Epworth Sleepiness Scale score in this group was 11 (range 0-22). The overnight 
diagnostic sleep study showed a mean total Apnoea Hypopnea Index (AHI) of 30/h 
(SD +/-26/h). The range for AHI was 0-113.  
4.2 Comparing two methods of artefact removal (manual vs 
ICA) 
4.2.1 Checking data for normal distribution 
Extracted qEEG data were checked for the normality of the distribution by calculating 
the mean and median, as well as using boxplots and histograms. All qEEG 
measurements obtained either with manual artefact removal or ICA in alpha, delta, theta 
and beta power, as well as the DFA scaling exponent in eyes open and eyes closed 
status were suitable for parametric statistical analysis. 
4.2.2 Preparation of data for analysis 
For manual analysis of the 83 patient qEEG data, the student screened a total of 3990 
epochs. If an artefact was identified, the epoch was marked as ‘noisy’ and was excluded 
from the manual analysis. During manual artefact removal of the EO section, 909 (46%) 
out of 1992 epochs were excluded as noisy. The EC section had 287 (14%) 5-second 
epochs removed from 1998 epochs.  
During manual scoring, six patients did not have acceptable EEG data in the EO state 
due to gross contamination by eye blinks. Hence, in the manual analysis, data from 76 
patients were used in the eyes open state and all 83 patient’s data were used in the eyes 
closed state. 
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In the automated analysis, epochs with artefacts were not excluded, however, artefacts 
were ‘corrected’ by the ICA. 
To explore the agreement and interchangeability of both methodologies of artefact 
removal, the following tests were conducted in each of the 10 EEG parameters 
measured below (Table 4.1). 
Table 4.1 Defining EEG measurements compared between manual (n) and ICA 
(i) artefact removal methods 
EEG frequency bands Manual artefact removal result (n) 
ICA artefact 
removal result (i) 
Delta power Eyes Open Delta EO n Delta EO i 
Theta power Eyes Open Theta EO n Theta EO i 
Alpha power Eyes Open Alpha EO n Alpha EO i 
Beta power Eyes Open Beta EO n Beta EO i 
Delta power Eyes Closed Delta ECn Delta EC i 
Theta power Eyes Closed Theta ECn Theta EC i 
Alpha power Eyes Closed Alpha ECn Alpha EC i 
Beta power Eyes Closed Beta ECn Beta EC i 
DFA scaling exponent Eyes Open DFA SE EO n DFA SE EO i 
DFA scaling exponent Eyes Closed DFA SE EC n DFA SE EC i 
 
4.2.3 Paired t-tests 
Ten EEG parameters, namely, Delta power EO and EC, Theta power EO and EC, Alpha 
power EO and EC, Beta power EO and EC, and DFA scaling exponent EO and EC were 
tested for differences between the two artefact removal methods. Paired t-tests were 
performed using SPSS statistics software. 
The eyes-open theta density (p=0.207) and eyes open DFA scaling exponent (p=0.136) 
did not show a statistically significant difference between the mean power densities 
when comparing manual artefact removal with ICA. However, rather surprisingly, the 
Delta density EO (p=0.034), EC (p< 0.001), Theta density EC (p=0.006), Alpha density 
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EO (p=0.03), EC (p<0.001) and Beta density (0.002) all showed statistically significant 
differences of the mean power density of each of the waveform frequencies.  
The DFA scaling exponent EC also showed statistically significant differences between 
the values of manual and ICA scoring.  
Higher power density values were observed in ICA artefact removal method in Delta 
EO, Beta EO, Theta EC, Alpha EC, Beta EC and DFA SE EC and EO. The manual 
scoring showed higher power density values in Theta EO, alpha EO and Delta EC. 
However, the absolute difference between the means obtained by the two methods of 
artefact removal for each EEG measurement was small (Table 4.2). 
Table 4.2 Comparison of ICA (i) and manual (n) artefact removal measurements 
using paired t-test 
EEG 
Pair 
Comparison between ICA (i) 
And manual (n) EEG power 
spectrum and DFA during EO 
Mean 
Difference SD t df 
Statistical 
Significance 
Pair 1 Delta EO i -Delta EO n  0.036 0.14 2.16 76 p<0.05 
Pair 2 Theta EO i – Theta EO n -0.004 0.03 1.27 76 p=0.207 
Pair 3 Alpha EO i –Alpha EO n -0.014 0.05 2.20 76 p<0.05 
Pair 4 Beta EO i – Beta EO n 0.089 0.08 8.76 76 p<0.001 
Pair 5 Delta EC i- Delta EC n -0.040 0.08 4.40 82 p<0.001 
Pair 6 Theta EC i – Theta EC n 0.006 0.02 2.80 82 p<0.01 
Pair 7 Alpha EC i – Alpha EC n 0.017 0.03 4.95 82 p<0.001 
Pair 8 Beta EC i – Beta EC n 0.017 0.04 3.26 82 p<0.01 
Pair 9 DFA SE EO i - DFA SE EO n  0.019 0.11 1.50 76 p=0.136 
Pair 10 DFA SE EC i - DFA SE EC n 0.037 0.08 4.25 82 p<0.001 
 
4.2.4 Effect size 
As there was a significant difference in means between the manual and ICA artefact 
removal methods in eight out of the 10 EEG parameters tested, the effect size was 
calculated to explore the magnitude of the difference between the two methods on each 
of the measurements.  
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Results showed delta power EO 0.2/EC 0.2, theta power EO 0.1/EC 0.15, alpha power 
EO 0.16/EC 0.16, beta power EO 1.0/EC 0.17. In the DFA scaling exponent, the effect 
size was EO 0.1/ EC 0.2 (Table 4.3). 
Table 4.3 Effect size for changes observed between two artefact removal 
methods 
Paired sample of EEG measurement Effect size Interpretation 
Delta EO i -Delta EO n  0.2 small 
Theta EO i – Theta EO n 0.1 small 
Alpha EO i –Alpha EO n 0.1 small 
Beta EO i – Beta EO n 1.0 large 
Delta EC i- Delta EC n 0.2 small 
Theta EC i – Theta EC n 0.1 small 
Alpha EC i – Alpha EC n 0.1 small 
Beta EC i – Beta EC n 0.1 small 
DFA SE EO i - DFA SE EO n  0.1 small 
DFA SE EC i - DFA SE EC n 0.2 small 
 
Although there was a significant difference in the mean power density in eight out of 
the 10 EEG parameters calculated for the two artefact removal methods, the effect size 
was found to be very small <0.2. Based on Cohen’s rule of thumb for interpreting effect 
sizes, a ‘small’ effect size is considered to be <0.20, a ‘medium’ effect size is 
approximately 0.50 and a ‘large’ effect size is considered to be >.80 (66). The beta 
power density during EO state demonstrated a large effect size. 
4.2.5 Bland-Altman plots 
To further clarify the scatter of the difference between the measurements of the 2-
artefact removal methods, Bland-Altman plots (B&A plots) were used to identify if the 
differences between the measurements were similar across a range of values and to 
decide if limits of agreement were narrow. The limitation with our measurements when 
using Bland-Altman plots was that the measurements for PSA and DFA scaling 
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exponents did not have an established measurement range, unlike other common 
physiological measurements, for example, blood pressure in mmHg or height in 
centimetres. However, a tighter scatter around the mean would imply that there were 
narrow-based limits of agreement.  
The Bland-Altman plots demonstrated a tight scatter around the mean during the eyes 
closed segment in comparison to the eyes open segment in all 10 EEG measures 
investigated. The beta power density during the eyes open segment had the most 
amount of scatter in keeping with the higher effect size noted during earlier testing.  
 
Figure 4.1 Bland-Altman plots for delta 
power EO 
Figure 4.2 Bland-Altman plots for delta 
power EC 
 
 
Figure 4.3 Bland-Altman plots for theta 
power EO 
Figure 4.4 Bland-Altman plots for theta 
power EC 
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Figure 4.5 Bland-Altman plots for alpha 
power EO 
Figure 4.6 Bland-Altman plots for alpha 
power EC 
 
  
Figure 4.7 Bland-Altman plots for beta 
power EO 
Figure 4.8 Bland-Altman plots for beta 
power EC 
 
Figure 4.9 Bland-Altman plots for DFA EO Figure 4.10 Bland-Altman plots for DFA EC
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4.2.6 Pearson’s correlation coefficient 
Given the small effect size, to further explore the correlation between the two 
methodologies of artefact removal, scatter plots were created for both manual and ICA 
methods in the 10 EEG measures explored above.  
Pearson’s correlation was calculated to find out the strength of the association between 
the two methodologies in each of the power densities of delta, theta, alpha and beta 
during the eyes closed and eyes open states, as well as scaling exponent both eyes open 
and eyes closed states. There was a very strong correlations displayed between all 
power densities across both eyes closed and open states, with the eyes closed state 
having an even tighter association. 
The Delta power EO 0.609/EC 0.871, Theta power EO 0.666/EC 0.871, Alpha power 
EO 0.783/EC 0.954 and Beta power EO 0.664/EC0.874 associations were highly 
statistically significant (p<0.0001). 
The DFA scaling exponent analysis in both eyes closed and open states showed an even 
tighter association between the two methods of artefact removal (DFA scaling exponent 
EO 0.773/EC 0.898). This association was highly statistically significant (p<0.0001) 
(Table 4.4). 
Table 4.4 Pearson’s correlation coefficient comparing the correlation between 
two different artefact removal methods 
Paired sample of EEG measurement N Correlation Sig. 
Delta EO i -Delta EO n  77 0.609 p<0.001 
Theta EO i – Theta EO n 77 0.666 p<0.001 
Alpha EO i –Alpha EO n 77 0.783 p<0.001 
Beta EO i – Beta EO n 77 0.664 p<0.001 
Delta EC i- Delta EC n 83 0.871 p<0.001 
Theta EC i – Theta EC n 83 0.871 p<0.001 
Alpha EC i – Alpha EC n 83 0.954 p<0.001 
Beta EC i – Beta EC n 83 0.874 p<0.001 
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DFA SE EO i - DFA SE EO n  77 0.773 p<0.001 
DFA SE EC i - DFA SE EC n 83 0.898 p<0.001 
 
These associations were further explored with scatter plots. 
Figure 4.11 Correlation between manual 
and ICA artefact removal 
methods in delta power (EO) 
Figure 4.12 Correlation between manual 
and ICA artefact removal 
methods in delta power (EC) 
 
  
Figure 4.13 Correlation between manual 
and ICA artefact removal 
methods in theta power (EO) 
Figure 4.14 Correlation between manual 
and ICA artefact removal 
methods in theta power (EC) 
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Figure 4.15 Correlation between manual 
and ICA artefact removal 
methods in alpha power (EO) 
Figure 4.16 Correlation between manual 
and ICA artefact removal 
methods in alpha power (EC) 
 
  
Figure 4.17 Correlation between manual 
and ICA artefact removal 
methods in beta power (EO) 
Figure 4.18 Correlation between manual 
and ICA artefact removal 
methods in beta power (EC) 
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Figure 4.19 Scaling exponent (EO) 
correlation between manual 
and ICA artefact removal 
methods in DFA (EO) 
Figure 4.20 Scaling exponent (EO) 
correlation between manual 
and ICA artefact removal 
methods in DFA (EO) 
 
4.2.7  Intra-class correlation for absolute agreement  
By using the two artefact removal methods the results obtained for each EEG 
measurement essentially would be similar if the two methodologies had absolute 
agreement. If this was true, one method could be interchanged for the other without 
errors and with good reproducibility.  
To test the absolute agreement between the two methods of artefact removal, intra-class 
correlation coefficient was performed. All PSA power densities and DFA scaling 
exponents in both eyes open and eyes closed states showed statistically significant 
absolute agreement (Table 4.5).  
All PSA parameters obtained by the two methodologies showed good agreement 
although the degree of agreement varied between 0.2 and 0.8.  
The DFA scaling exponents demonstrated a stronger agreement between the two 
artefact removal methods (0.6-0.9) with the eyes closed segment showing perfect 
agreement enabling good interchangeability (ICC 0.9; 95% CI 0.8-0.9). 
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Table 4.5 Intra-class correlation coefficient for absolute agreement of the two 
artefact removal methods 
Pair Absolute agreement and 95% CI Significance 
Delta EO i -Delta EO n  0.6 (0.4-0.7) p<0.0001 
Theta EO i – Theta EO n 0.7 (0.5-0.7) p<0.0001 
Alpha EO i –Alpha EO n 0.7 (0.6-0.8) p<0.0001 
Beta EO i – Beta EO n 0.6 (0.5-0.7) p<0.0001 
Delta EC i- Delta EC n 0.3 (0.2-0.5) p=0.002 
Theta EC i – Theta EC n 0.3 (0.1 - 0.4) p=0.006 
Alpha EC i – Alpha EC n 0.8 (0.7-0.8) p<0.0001 
Beta EC i – Beta EC n 0.2 (0.01-0.4) p=0.02 
DFA SE EO i - DFA SE EO n  0.8 (0.6 - 0.8) p<0.0001 
DFA SE EC i - DFA SE EC n 0.9 (0.8 - 0.9) p<0.0001 
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Table 4.6 Summary of the results of statistical methods used in comparing the ICA and manual artefact removal methods 
Paired T test Effect size Pearson’s correlation coefficient 
Intra class correlation 
coefficient Bland Altman Plots 
Pair 
Mean 
difference Sig. 
Effect 
size 
Interpretati
on Correlation Sig. 
Absolute 
agreement Sig. 
Scatter around the 
mean 
Limits of 
agreement 
Delta EO i -Delta EO n  0.036 P<0.05 0.2 Small 0.609 P<0.001 0.6 P<0.0001 Tight Narrow 
Theta EO i – Theta EO n 0.004 P=0.207 0.1 Small 0.666 P<0.001 0.7 P<0.0001 Tight Narrow 
Alpha EO i –Alpha EO n 0.014 P<0.05 0.1 Small 0.783 P<0.001 0.7 P<0.0001 Tight Narrow 
Beta EO i – Beta EO n 0.089 P<0.001 1.0 Large 0.664 P<0.001 0.5 P<0.0001 Scatter around the mean is large Broad 
Delta EC i- Delta EC n 0.040 P<0.001 0.2 Small 0.871 P<0.001 0.3 P=0.002 Tighter Narrower than EO 
Theta EC i – Theta EC n 0.006 P<0.01 0.1 Small 0.871 P<0.001 0.3 P=0.006 Tighter Narrower than EO 
Alpha EC i – Alpha EC n 0.017 P<0.001 0.1 Small 0.954 P<0.001 0.8 P<0.0001 Tighter Narrower than EO 
Beta EC i – Beta EC n 0.017 P<0.01 0.1 Small 0.874 P<0.001 0.2 P=0.02 Tighter Narrower than EO 
DFA SE EO i - DFA SE EO n  0.019 P=0.136 0.1 Small 0.773 P<0.001 0.8 P<0.0001 Very tight Extremely narrow 
DFA SE EC i - DFA SE EC n 0.037 P<0.001 0.2 Small 0.898 P<0.001 0.9 P<0.0001 Very tight Extremely narrow 
 
50 
4.2.8 Correlation of manual and ICA artefact removal methods to 
performance test results 
In this study, two artefact removal methods (manual and ICA) were compared with a 
battery of performance testing. The results obtained by both artefact removal methods 
were correlated to performance testing to identify if both methods gave similar results. 
DFA scaling exponent: Comparison of DFA scaling exponent (manual vs ICA) and 
performance tasks 
A significant correlation for using DFA scaling exponent was observed only during the 
finger tapping task and four-choice reaction time tasks. These two tasks were used to 
compare the results obtained by manual and ICA artefact removal (Appendix Table 6): 
(i) finger tapping test ICA EO r=0.41, manual EO r=0.41 (Figures 4.21 & 4.22)’ and (ii) 
four-choice reaction time ICA EC r=-0.26, manual EC r=-0.26 (Figures 4.23 & 4.24).  
  
Figure 4.21 Correlation between DFA 
extracted by ICA and finger 
tapping task 
Figure 4.22 Correlation between DFA 
extracted manually and finger 
tapping task 
 
When a statistically significant result occurred, both artefact removal methods gave 
identical results with similar trends in DFA analysis. This was further explored using 
scatter plots. 
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Figure 4.23 Correlation between DFA 
extracted by ICA and 
4-choice reaction time task 
 
Figure 4.24 Correlation between DFA 
extracted manually and 
4-choice reaction time task 
 
PSA analysis: Comparison of PSA (manual vs ICA) and performance tasks 
PSA analysis was done using combined frequencies to measure EEG slowing. One 
method used in this study to calculate EEG slowing was using delta and theta over the 
alpha and beta equation. In this study, two artefact removal methods were used to obtain 
separate PSA values for statistically significant results and to compare the agreeability.  
PSA measurements had significant correlations only in mean reaction time and median 
reaction time in the AusEd driving task (Appendix Table 7). A comparison was made 
between the manual and ICA results. The mean reaction time to braking in response to 
trucks was ICA EC r=0.23, manual r=0.29 and the median reaction time in response to 
trucks was ICA EC r=0.24, manual EC r=0.3. 
When a statistically significant result was obtained by PSA measurements, there was a 
correlation of a similar trend between manual and ICA artefact removal methods. 
However, the absolute numbers of the correlation coefficient were different. This was 
further explored using scatter plots (Figures 4.25 to 4.28). 
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Figure 4.25 Correlation between PSA 
extracted by ICA and mean 
reaction time 
Figure 4.26 Correlation between PSA 
extracted manually and mean 
reaction time 
 
  
Figure 4.27 Correlation between PSA 
extracted by ICA and median 
reaction time 
Figure 4.28 Correlation between PSA 
extracted manually and median 
reaction time 
 
4.3 Correlation of EEG parameters to vigilance testing  
The gold standard artefact removal method uses manual scoring. During manual 
scoring, very tight screening was done to rule out all muscle artefacts and eye blinks 
that could be interpreted as delta waves, thereby giving false high ‘sleepy EEG’ values. 
Due to the observed differences between the two artefact removal methods, as 
previously explained, from this point onwards all correlations to performance testing 
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was done using the manual artefact removal method alone as the gold standard. The full 
results of the comparison between EEG measurements and performance testing are 
described later in Section 4.2.5. 
During this study, EEG slowing was measured in three ways: 
1. Using PSA ratio of delta power and theta power to alpha power and beta power, 
this was a ratio of slow frequencies: delta and theta (indicating sleepiness) to the 
faster frequencies: alpha and beta (indicating alertness). It was selected as a 
global index for EEG slowing. A higher value indicates reduced alertness (43).  
2. Using PSA ratio of theta to alpha power waves (measuring the ratio between 
more drowsy waves to the more alert waves) a higher value indicated reduced 
alertness (41). 
3. Using DFA scaling exponent (higher the value of scaling exponent, more 
sleepier the subject) (48). 
Each EEG slowing parameters were measured during eyes open and eyes closed state. 
In the next step, Pearson’s correlation coefficient was used to determine the correlations 
between EEG slowing and the results of sleep study data, self-rated questionnaires, 
AusEd driving simulator testing, anxiety and depression scales and vigilance testing.  
4.3.1 Sleep study data 
Sleep study data looked at sleep efficiency, arousal index, proportion of time with 
saturations below 90%, total apnoea hypopnea index (AHI), non-rapid eye movement 
(NREM) AHI, rapid eye movement (REM) AHI and minimum saturations recorded 
during the sleep period. The sleep study parameters were correlated against the 
measurements for EEG slowing (Appendix Table 8).  
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Only a single EEG slowing parameter: delta+theta/alpha+beta (EC) was associated with 
higher arousal index (r=0.299, p<0.01), increased NREM AHI (r=0.268, p<0.05) and 
total AHI (r=0.263, p<0.05). The correlations were statistically significant but weak.  
To explore the validity of these results, scatter plots were constructed (Figures 4.29, 
4.31 and 4.33). They suggested that the correlations seen were secondary to two outliers 
in the dataset.  
The analysis was repeated following removal of these two outliers who had 
delta+theta/alpha+beta (EC) value >15.00. Following removal of the outliers, the EEG 
slowing measured by delta+theta/alpha+beta (EC) did not show significant correlations 
to total AHI (r=-0.05, p=0.7), arousal index (r=0.005, p=0.96) or NREM AHI (r=-0.024, 
p=0.8) (Figures 4.30, 4.32 and 4.34). 
  
Figure 4.29 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) EC and total AHI  
Figure 4.30 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) EC and total AHI 
(following removal of two 
outliers) 
 
Sleep efficiency and nocturnal hypoxia did not have an association with EEG slowing. 
Other EEG slowing measurements of theta/alpha and DFA scaling exponent did not 
show any correlation for all tested sleep study parameters. 
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Figure 4.31 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) EC and arousal index 
Figure 4.32 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) and arousal (following 
removal of two outliers) 
 
  
Figure 4.33 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) and NREM AHI  
Figure 4.34 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) and NREM AHI (following 
removal of two outliers) 
 
In summary, EEG slowing did not show any significant correlation to sleep study data 
of total AHI, NREM AHI, arousal index, nocturnal hypoxia or sleep efficiency. 
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4.3.2 Questionnaires for sleepiness (ESS and KSS)  
The EEG slowing measured by combined frequencies of delta+theta/alpha+beta EO 
(r=-0.2, P=0.01) and EC (r=-0.2, p=0.07) state or theta/delta during EO (r=-0.08, p=0.4) 
did not show any correlation with ESS. However, the theta/alpha densities during EC 
(r=-0.3, p=0.01) did show weak correlations but the direction of the association was 
opposite to what was expected. This was not clinically acceptable (worsened EEG 
slowing associated with improved sleepiness), therefore, it was not taken as a valid 
correlation. The DFA scaling exponent during eyes open (r=-0.2, p=0.1) and eyes 
closed (r=-0.13, p=0.3) states did not correlate with ESS (Appendix Table 9). 
Furthermore, the KSS score did not show correlations to PSA or DFA measurements of 
EEG slowing (Appendix Table 9) 
In summary, there was no significant correlation noted between EEG slowing measured 
by PSA or DFA and subjective self-rated sleepiness scores.  
4.3.3 AusEd driving simulator 
The AusEd driving simulator measured domains of steering deviation from the centre of 
the lane, steering deviation from the median lane position, speed deviation outside the 
60-80 km/h zone, mean breaking time in reaction to trucks, standard deviation of the 
reaction time, median reaction time in response to trucks and the number of crashes 
(Appendix Table 7). These parameters were correlated to the three measurements of 
EEG slowing as outlined above during the EO and EC states. 
Again, the same EEG slowing measurement as before (delta+theta/alpha+beta EC) had 
weak but statistically significant correlation to the mean reaction time in response to 
trucks (r=0.296, p<0.01) and the median reaction time (r=0.302 p<0.01). This 
relationship was explored further by using scatter plots (Figures 4.35 and 4.37). 
The same two outliers noted previously for the delta+theta/alpha+beta EC measurement 
also influenced these results. Following removal of the two outliers, the mean reaction 
time (r=0.063, p=0.6) and median reaction time (r=0.09, p=0.4) did not show significant 
correlations to the EEG slowing (Figures 4.36 and 4.38). The EEG slowing measured 
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by theta/alpha and DFA scaling exponent during the EO and EC states did not correlate 
with driving performance.  
  
Figure 4.35 Correlation between mean 
reaction time and EEG slowing 
(delta+theta/alpha+delta) 
Figure 4.36 Correlation between mean 
reaction time and EEG slowing 
(delta+theta/alpha+delta) 
(following removal of two 
outliers) 
 
  
Figure 4.37 Correlation between median 
reaction time and EEG slowing 
(delta+theta/alpha+delta) 
Figure 4.38 Correlation between median 
reaction time and EEG slowing 
(delta+theta/alpha+delta) 
following removal of two 
outliers 
 
In summary, EEG slowing measured by PSA and DFA did not show any correlation to 
driving performance. 
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4.3.4 Questionnaire for anxiety and depression (DASS and FOSQ) 
The depression and anxiety questionnaire and the functional assessment of sleep 
questionnaire were compared with EEG slowing measured by PSA and DFA methods. 
Again, the same EEG measurement delta+theta/alpha+beta (EC) demonstrated statically 
significant correlation with the DASS score for anxiety (r=0.297, p<0.01) (Appendix 
Table 10). However, the scatter plot below (Figure 4.39) showed that the correlation 
was a result of two outliers identified before changing the slope of line for best fit.  
Following removal of the outliers, the correlations of EEG slowing to DASS score for 
anxiety became non-significant (r=-0.09, p=0.4) (Figure 4.40). The other subgroups of 
the DASS questionnaire, including the score for stress and depression, did not show any 
correlations to the measurements of EEG slowing. The FOSQ score for vigilance did 
not show any correlation to EEG slowing either, as measured by all three methods 
during the EO and EC states. 
  
Figure 4.39 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) EC and DASS score for 
anxiety 
Figure 4.40 Correlation between EEG 
slowing (delta+theta/alpha+ 
beta) EC and DASS score for 
anxiety (following removal of 
outliers) 
 
In summary, the EEG slowing measurements with PSA and DFA were not associated 
with the DASS questionnaire or FOSQ scores.  
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4.3.5 Tests for performance  
Fourteen individual tests were performed to assess daytime functioning (Appendix 
Tables 11, 12 & 13). 
1. Attention: Four choice reaction test; finger tapping test; visual attention test; 
attention switching (trail marking test A) and sustained attention task. 
2. Tests for memory: Digit span; memory recall; and span of visual memory.  
3. Tests for executive functioning: Tower of London, trail marking test, Stroop test 
and Maze test. 
4. Verbal fluency: Spot the real word test; word generation (FAS test); and word 
generation (animal test). 
EEG slowing was measured using PSA measurements (delta+theta/alpha+beta and 
theta/ alpha) and DFA scaling exponent. 
The only positive results obtained from Pearson’s correlation coefficient were ‘spot the 
real word’ test. This test had a negative correlation to the EEG slowing measured by 
delta+theta/alpha+beta EC state (r=-0.247, p<0.05) (Figure 4.41).  
However, the scatter plot demonstrates that this result is again secondary to the one 
extreme outliers noted with this EEG measurement during the previous analysis. 
Following removal of the outlier, the correlations became non-significant (r=-0.12, 
p=0.24) (Figure 4.42). 
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Figure 4.41 EEG slowing measured by 
(delta+theta/alpha+beta) EC 
and spot the real word test 
Figure 4.42 EEG slowing measured by 
(delta+theta/alpha+beta) EC 
and spot the real word test 
(following removal of two 
outliers) 
 
In summary, the measured performance tests did not show any correlation to EEG 
slowing when measured using PSA or DFA. 
4.4 Assessing the relationship between PSA and DFA in 
awake EEG 
The DFA scaling exponent and PSA measurements measured by individual frequency 
densities had previously been shown to correlate well with each other (48). All 
frequencies of the power spectrum were shown to be either positive (delta power) or 
negative (alpha power) correlated to the DFA scaling exponent in both eyes closed and 
eyes open states. 
4.4.1 Comparing individual PSA frequencies to DFA scaling exponent 
In this dataset, the DFA scaling exponent was compared with individual delta, alpha, 
theta and beta power densities and correlations assessed using Pearson’s correlation co-
efficient (Table 4.6). There was a very strong positive correlation between the DFA 
scaling exponent and delta power during both eyes open (r=.800, p <0.01) and eyes 
closed (r=0.872, p<0.01) states.  
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There was a strong negative correlation between the DFA scaling exponent and alpha 
power in both eyes open (r=-.672, p<0.01) and eyes closed (r=-.788, p<0.01) states, 
which was in keeping with the previous published data (48). 
All other power spectrum densities were correlated significantly except for theta power 
when the eyes were open (r=0.064, p=0.579). 
Table 4.7 Pearson’s correlation of DFA scaling exponent versus individual 
power spectrum frequencies  
Comparison between KDT SE and individual power 
densities 
Pearsons correlation 
coefficient 
KDT EO Delta power EO r=0.80 
p<0.01 
 Theta power EO r=0.06 
p=0.56 
 Alpha power EO r=-0.67 
p<0.01 
 Beta power EO r=-0.43 
p<0.01 
KDT EC Delta power EC r=0.87 
p<0.01 
 Theta power EC r=-.26 
p=0.02 
 Alpha power EC r=-.79 
p<0.01 
 Beta power EC 
 
r=-.58 
p<0.01 
 
Comparing combined PSA frequencies to DFA scaling exponent 
Following this, the EEG slowing measured by combined PSA frequencies of 
delta+theta/alpha+beta and theta/alpha was correlated against the DFA scaling exponent 
to determine the correlations. This analysis was done for corresponding eyes open and 
eyes closed states of the DFA scaling exponent.  
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Table 4.8 Pearson’s correlation of DFA scaling exponent versus combined 
power spectrum frequencies 
EEG slowing measurement 
using PSA (EO) DFA (EO) 
EEG slowing measurement 
using PSA (EC) DFA (EC) 
Alpha/theta (EO) r=0.581 
p<0.0001 
Alpha/theta (EC) r=0.627 
p<0.0001 
Delta+theta/alpha+beta(EO) r=0.750 
p<0.001 
Delta+theta/alpha+beta (EC) r=0.683 
p<0.0001 
 
Comparing the relationship between the DFA scaling exponent and EEG slowing 
measured by PSA, there was an excellent correlation between the two measurements as 
demonstrated below. These relationships are consistent in both eyes open and eyes 
closed states (Table 4.7). A graphical representation of this correlation was made by 
using scatter plots and found the correlations to be robust (Figures 4.43, 4.44, 4.45 and 
4.46). 
  
Figure 4.43 Correlation between DFA and 
PSA measured by theta/alpha 
(EC) 
Figure 4.44 Correlation between DFA and 
PSA measured by theta/alpha 
(EO) 
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Figure 4.45 Correlation between DFA and 
PSA measured by delta+ 
theta/alpha+beta (EC) 
Figure 4.46 Correlation between DFA and 
PSA measured by delta+ 
theta/alpha+beta (EO) 
 
Correlating three EEG slowing measurements to performance testing 
Correlating to performance testing assessed the degree of agreement between three 
individual methods of EEG slowing. Steering deviation from the left lane was taken as a 
random outcome measure. All three methods of EEG slowing showed similar 
correlations although the numerical value for the correlation coefficient was not 
identical (Table 4.8) and the correlations were not statistically significant. 
Scatter plots were used to demonstrate the similar trend between the three methods of 
EEG slowing even though the correlation was not significant (Figures 4.47, 4.48 and 
4.49).  
Table 4.9 Comparing three EEG slowing methods and the steering deviation 
test 
EEG slowing during Steering deviation from the left lane. 
Delta+theta/alpha+beta EO  r=-0.14, 
Theta/alpha manual EO r=-0.15 
DFA Eyes Open  r=-0.13 
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Figure 4.47 Correlation between PSA (delta+theta/alpha+beta) EO and steering deviation
 
 
Figure 4.48 Correlation between PSA (theta/alpha) EO and steering deviation 
 
 
Figure 4.49 Correlation between DFA scaling exponent (EO) and steering deviation 
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5. DISCUSSION 
5.1 Summary of Findings 
Overall, DFA and PSA look at the same effect of EEG slowing in different ways, that 
is, measuring EEG fluctuations versus EEG frequencies respectively. During a 
comparison of the two artefact removal methods using multiple statistical tests, PSA 
metrics were found to be vulnerable to the influence of artefacts in contrast to the novel 
EEG analysis method DFA which was far superior to PSA metrics in withstanding 
artefact. When a statistically significant result was present, both manual and ICA 
artefact removal methods produced identical results with DFA but not with PSA. 
The battery of performance testing gave statistically significant but weak correlations 
only with one measurement of EEG slowing: delta+theta/alpha+beta EC. Further 
exploration of these correlations using scatter plots demonstrated that positive results 
were due to two significant outliers. Following removal of the outliers, no significant 
association between EEG slowing and performance testing was found. 
5.2 Comparing two methodologies of artefact removal 
When drawing inferences from EEG parameters, artefact removal is of paramount 
importance, as we should ensure that the waves analysed to ascertain drowsiness 
originates from the brain and not an artefact that occurred due to muscle movements and 
eyes blinks. 
Several methods of eye artefact removal have been noted in the literature. Berg and 
Scherg (67) in 1991 proposed a method of eye artefact removal using aspatio-temporal 
dipole model. In this method priori assumptions are made about the number of dipoles 
for blinks and other eye movements, which then led to inaccuracies in the dipole model 
that subsequently lead to inaccuracies in the contributions from EOG to EEG. To 
overcome this problem they later on proposed another technique for removing ocular 
artefacts, by using principal component analysis (PCA) (68). Here, EEG and EOG 
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signals were simultaneously collected while the subject performed standard eye 
movements and blinks. Then, a PCA of the variance in these calibration signals gave 
major components representing blinks and other eye movements. Corrected EEG data 
could be obtained by removing these components through the simple inverse 
computation. The PCA method was demonstrated to be superior to the spatiotemporal 
dipole model of removing eye artefacts (68). 
The problem noted with PCA was that it cannot completely separate some artefacts 
from cerebral activity, especially when they both have comparable amplitudes (69).  
The ICA method was originally proposed to solve this blind source separation problem 
to recover independent source signals (70). The ICA algorithms have since been used to 
separate neural activity from muscle and blink artefacts in spontaneous EEG data and 
had been shown to help tracking alertness (71). 
The two EEG artefact removal methods analysed here were ICA (automated) and 
manual scoring. During the eyes open state, artefacts are more troublesome as expected 
due to the eye blinking more frequently. 
With manual scoring, the ‘noisy’ epochs were stringently marked in order to obtain as 
‘clear’ a signal as possible. While this resulted in a clean measure of the EEG 
waveforms, a larger number of epochs had to be excluded from the analysis. During the 
eyes open state, 45% epochs were rejected while during the eyes closed state, only 14% 
were rejected. This carries the disadvantage of having sparse data for some patients who 
have more artefacts in the EEG. Due to the sparse data, the mean value of the ‘clean’ 
epochs may not be a true representation of all EEG epochs. Furthermore, the ‘clean’ 
epochs alone may not be a true representation of all the EEG data of that patient. 
This shows the obvious advantage in using ICA as an artefact removal method because 
ICA does not ‘reject’ epochs. Instead it identifies the artefactual waveforms by using a 
reference from the EOG and ‘corrects’ the EEG waveform. Therefore, all measured 
epochs were included, making the full use of the EEG data which would provide a more 
reliable EEG representation for that patient. 
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The gold standard measurement for artefact removal is by manually scoring individual 
epochs. Given the above advantage of increased power in measurements, as well as the 
ability to analyse large amounts of data in a short time in a consistent pattern, ICA could 
be an alternative to manual scoring of artefacts. Hence, it is important to establish the 
interchangeability and degree of agreement between ICA and manual scoring.  
A literature review identified several statistical methods that measure the agreement 
between two measurements, as is the case with this study. Students’ t-tests, effect size 
measurement, intra-class correlation coefficient measurement, Bland-Altman plots and 
Pearson’s correlation coefficient were described as statistical methods that were used to 
compare agreement between two measurements. However, all statistical methods had 
their inherent limitations and a single superior method was not found. Because all 
methods for the measurement of agreement have limitations, the overall impression 
given from several statistical approaches were thought to give a better measure of 
reliability and agreement (72). However, it is also important to realise that there are 
specific drawbacks in every method. Hence, when interpreting the results of an 
individual statistical method, the applicability of that result depends on the clinical 
context (73).  
Throughout this discussion the comparison is made between 10 EEG waveforms 
measured by ICA and manual artefact removal methods, namely delta power EO/EC, 
theta power EO/EC, alpha power EO/EC, beta power EO/EC and DFA scaling exponent 
EO/EC (Table 4.1). 
5.2.1 Paired t-test 
The paired t-test was measured for 10 EEG waveforms, namely delta power, theta 
power, alpha power, beta power in EO and EC states, and the DFA scaling exponent EC 
and EO. Overall, there was a statistically significant difference in eight out of 10 
waveforms measured. This showed a definite difference of the arithmetic mean in eight 
out of the 10 EEG measurements. However, the mean difference between the two 
methods in each waveform was very small, ranging from 0.006 to 0.089.  
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5.2.2 Effect size 
The effect size of the above difference is important to make clinical decisions, as 
statistical significance does not automatically imply clinical significance. The effect size 
varies from 0 to 1.0 based on Cohen’s article for interpreting effect sizes: a ‘small’ 
effect size is considered to be <0.20 (66). Calculating an effect size is also a good 
measure for a clinician to understand the magnitude of the effect to make a clinical 
judgement over a statistical value. With prior knowledge of the scale of a measurement, 
an effect size could be calculated clinically to be small, medium or large. In this data 
set, nine out of the 10 EEG measurements had a small effect size statistically and 
clinically. This indicates that although there was a statistically significant difference 
between the variables measured with the paired t-tests, the magnitude of the difference 
was small.  
Only beta power EO had a large effect size. Bland-Altman plots were used to explore if 
this large effect size of the beta power EO could be due to a random error or bias. 
However, beta waves (low amplitude, high frequency waves) are seen during 
wakefulness. When measuring drowsiness of an individual, the usual frequencies of 
interest are in the delta, theta and alpha ranges with beta activity being less relevant as it 
is a frequency of wakefulness rather than that of drowsiness. Beta activity is not 
commonly reported to be related to sleepiness, therefore, although there is a difference 
between manual and ICA markings of beta power, it may not be of relevance in the 
measurement of sleepiness.  
5.2.3 Pearson’s correlation coefficient 
To explore this noted difference in means during the paired t-test, the Pearson’s 
correlation coefficient was used. Pearson’s correlation coefficient assesses the closeness 
of the data to the line of best fit (74). Between manual and ICA measurements in each 
of the 10 EEG measurements, there was a significant correlation <0.001 in all 
waveforms measured. This was well demonstrated by the scatter plots showing a close 
relationship, which was stronger when eyes closed (range: r=0.871 to 0.954) to eyes 
open (range: r=0.609 to 0.783). This reflects a larger number of artefacts during the EO 
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state than the EC state. This correlation was much greater for DFA during both EO 
(r=0.773) and EC (r=0.898) than PSA metrics in keeping with the known robustness of 
the scaling exponent to withstand artefacts. 
5.2.4 Intra-class correlation coefficient (ICC) (2-way mixed model for 
agreement) 
The two artefact removal methods look at the same population, extracting the results for 
the same 10 EEG measurements. Hence, the results from the two methods should show 
agreement for them to be interchangeable in clinical practice. The intra-class correlation 
coefficient was used to assess this. 
McGraw and Wong defined the intra-class correlation coefficient for assessing 
agreement. The measurement obtained could be ICC for consistency or ICC for absolute 
agreement; this was either by excluding or not excluding the observer variance from the 
denominator mean square, respectively (75). The systematic variability due to observers 
is irrelevant for ‘ICC for consistency’ and relevant for ‘ICC for agreement’. The ICC 
ranges from 0 (no agreement) to 1 (perfect agreement), but it can be negative. 
Consequently, ICC values have no absolute meaning but the cut-off value of 0.75 
proposed by Fleiss (76) is used to signify a good agreement. This cut-off value had 
been disputed by another group led by Lee who argued that the absolute agreement in 
interclass correlation coefficient is considered interchangeable only when r>0.75, as 
well as the lower limit of 95% of CI for ICC is >0.75% (77). 
All 10 EEG measurements showed statistically significant correlations between the two 
artefact removal methods used. The analysis of EEG frequencies in delta, theta, alpha 
and beta EC/EO states showed a variable correlation between 0.2 and 0.8 between the 
two methods. Both EO and EC states had similar correlations. The tightest correlations 
were noted during DFA analysis (EO 0.8, EC 0.85). Again, this is a measure of the 
robustness of DFA to withstand artefact, hence, giving comparable results irrespective 
of the methodology used for artefact removal.  
An important limitation of ICC is that it is strongly influenced by the variance of the 
trait in the sample in which it is assessed (78). This may explain the lesser correlation 
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expressed by power spectrum parameters (lesser variability of the sample) versus the 
stronger correlation expressed by DFA measures showing a greater variance. 
5.2.5 Bland-Altman plots 
To assess agreement between two methods of clinical measurement, Bland and Altman 
proposed the limits of agreement approach (79). They emphasised that neither the 
paired t-test nor the intra-class correlation is appropriate for validating the 
interchangeability of two measurement methods and proposed using the mean of the 
two measurement methods to be plotted against the standard deviation of the difference 
between the two methods. 
Based on limits of agreement, deciding whether the agreement is acceptable or not is 
always clinical and not a statistical judgement because there is no measure of what a 
‘good’ agreement is (73). In general, the tighter the scatter around the mean difference, 
which demonstrates a narrower 2SD for that measurement, shows smaller difference 
between the measurements.  
The other important information that can be derived from the Bland-Altman plots are to 
ascertain if there is a systematic bias, as well as clarifying if the scatter about the mean 
difference increases as the magnitude of the measurement increases. 
The PSA metrics show a tight scatter around the mean difference. This tightness is more 
during the EC state than the EO state, therefore, demonstrating increased artefacts 
occurring during the EO state and PSA metrics vulnerability to artefacts during the EO 
state. The beta power EO shows most scatter around the mean in keeping with wider 
limits of agreement. The beta power EO (Figure 4.7) also demonstrates that there is 
existence of systematic bias. 
Once again, irrespective of the eyes closed or eyes open state, the DFA scaling exponent 
has very tight scatter around the mean with very small (95%) confidence interval of the 
mean difference. This shows the robustness of DFA to artefact. For the same reason, the 
EO and EC states give similar results in DFA. 
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5.2.6 Comparing manual and ICA measurements to performance test 
results 
All the above tests show that there is a significant arithmetic mean difference between 
the two methodologies of artefact removal in each of the EEG measurements. The effect 
size of this difference is small and a tight correlation exists between the two 
methodologies. This was explored further to identify if a statistically significant 
difference was clinically significant as well. 
PSA (using ICA and manual) versus a performance test with a significant 
association  
The results obtained for EEG slowing by using combination PSA frequencies of delta 
and theta over alpha and beta were correlated to performance testing. Positive results 
were obtained only from the AusEd driving simulator task domains of mean reaction 
time and median reaction time. (See Section 5.2 for EEG measurements and 
performance testing results.) 
The statistically significant correlations to the performance testing measured by PSA 
using either manual or ICA artefact removal method demonstrated results of similar 
trend. For example, the mean reaction time to braking in response to trucks ICA EC 
r=0.23, manual r=0.29. Median reaction time in response to trucks ICA EC r=0.24, 
manual EC r=0.3 
DFA (using ICA and manual) versus a performance test with a significant 
association  
When correlating the DFA to performance testing, a statistically significant result was 
noted only during the finger tapping test and four-choice reaction time (Section 5.2). 
The correlation was weak, however, when the DFA was obtained from the manual and 
ICA artefact removal methods were compared to the performance testing, identical 
correlations were obtained. There was no difference between the EO and EC states, and 
the trend was always the same, for example, finger tapping test ICA EO r=0.41, manual 
EO r=0.41; four choice reaction time ICA EC r=-0.26, manual EC r=-0.26. 
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Hence, with both manual and ICA artefact removal methods used, the DFA gave similar 
results for correlation to performance tasks. This was in keeping with previous research 
published by our group in validating the use of ICA as an artefact removal method in 
calculating DFA (48).  
This again showed how the novel EEG measurement DFA can withstand isolated 
artefacts like eye blinks without much influence on the outcome of the DFA 
measurement, hence, making it a very robust to artefacts.  
5.3  Using EEG as a method of assessing performance in OSA 
patients 
Impairment of vigilance in OSA patients was shown to affect not just one specific task 
but impairment over a wide range of attention tasks. In this study, we used a range of 
performance tasks that could be categorised broadly into tasks of attention (AusEd 
driving simulator (35); four choice reaction test (36); finger tapping test (37); visual 
attention test (59); attention switching (trail making test A) (60) and sustained attention 
task), tasks of memory (digit span (61); memory recall, span of visual memory (62)), 
executive tasks (Tower of London (44), trail making test, Stroop test and maze test), 
and verbal fluency (spot the real word test (64), FAS test and the animal test). The aim 
of this study is to investigate if there is a correlation between EEG slowing (indicative 
of drowsiness/lack of vigilance) and impaired performance.  
For this component of the analysis, only the manual artefact removal method results 
were used due to the previously explained difference noted with ICA. 
EEG slowing was calculated using the following three methods:  
1. PSA – delta & theta power/alpha & beta power (EO and EC state) 
2. PSA – theta power/alpha power (EO and EC state) 
3. DFA – scaling exponent (EO and EC state) 
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In correlating the above-mentioned three EEG slowing measurements to performance 
testing only a few tests yielded correlations. All statistically significant correlations 
were noted only with PSA (delta+theta/alpha+beta) EC measurements. Positive 
correlations were noted for total AHI, NREM AHI, arousal index, DASS score for 
anxiety, mean reaction time, median reaction time of the breaking in response to trucks 
during the AUSEd driving task and spot the real word test. All correlations were 
statistically significant but weak. When these correlations were explored further by 
using scatter plots, it was obvious that there was influence from two outliers, drastically 
changing the line of best fit. When the analysis was repeated after removing the two 
outliers, all the above results became non-significant. Hence, all three EEG slowing 
measurements of delta+theta/alpha+beta, theta/alpha and DFA did not show any 
significant correlations over the 14 individual performance tasks and AusEd driving 
simulator task.  
The battery of testing contained an array of tests that had been previously tested on 
OSA patients and had been found to be impaired compared to the controls (35, 36, 37, 
55, 56, 57, 81). Therefore, the correct tests had been applied, but none of the 
performance tests showed any significant correlation to EEG slowing. The possible 
explanation for a negative finding is outlined below.  
Firstly, performance testing was carried out the day after the awake EEG testing. Hence, 
the lag time between EEG testing from which we obtained measurements for EEG 
slowing and the actual performance test was about 15 hours. This may explain the lack 
of relationship. 
Secondly, the tests were carried out between 9 am and 12 noon after a full night’s sleep 
and at a time when the homeostatic drive for sleep was at its nadir, thus possibly 
contributing to improved performance during the testing period and attenuating the 
ability of a test to detect impairment. 
Thirdly, the inter individual variability that could occur during neurocognitive testing 
may have contributed to a negative study (80). 
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Finally, because testing was done under ‘controlled’ conditions, it did not give a true 
indication of how a participant would behave in real life when participants could be 
sleep-restricted and possibly had varying degrees of alcohol consumption that would 
impair their performance the next day. Add to this personal factors such as children, 
pets and environmental noises that impair sleep. These conditions were artificially 
controlled during the testing period, possibly leading to improved performance. This 
assumption is not applicable to all patients. Furthermore, some patients may have done 
the test poorly due to the first night effect in the laboratory resulting in more fragmented 
sleep with less sleep efficiency.  
The driving performance task did not yield positive results after dismissing the 
influential outliers, even though the driving performance task was executed soon after 
the 5-minute recording of awake EEG. Hence, the test was conducted in the evening 
(between 1600 and 1900 hours) when the participants have been awake throughout the 
day, the homeostatic sleep drive was high and the lag time between the EEG 
measurement and the tests was small.  
It could be determined that the test was not sensitive enough because it lasted only 30 
minutes. If the driving test was prolonged, a more positive result would be achieved as 
previously published data demonstrating significant driving impairment in OSA patients 
had utilised the driving task of more than 60 minutes (81). Another reason for a lack of 
positive results was that this was a simulated computer task and not a real life situation, 
hence, patients may not have the same level of motivation to perform at their best when 
their physical safety is not at risl. The breaking to trucks only appeared 10 times during 
the entire period, hence, this domain does not measure the attention during the total 
driving period.  
Once again, measuring EEG activity at the time of the task would give a more accurate 
understanding in correlation to performance. However, the disadvantage would be the 
marked muscle and eye blink artefact that would be expected in the EEG when the 
subject is constantly moving his/her eyes and head.  
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The performance tests were correlated against the subjective sleepiness scores of KSS 
and ESS, both of which did not show any correlation to performance. The anxiety and 
depression score, as well as the FOSQ score, failed to show correlation to performance 
testing as well. All sleep study data that was compared, including the total 
apnoea/hypopnea index; arousal index and nocturnal hypoxia did not correlate 
significantly to performance testing.  
5.4 Comparing the use of the novel method of EEG slowing 
(DFA scaling exponent) with PSA metrics  
The EEG slowing measured by activity in individual PSA densities correlated well with 
DFA measurements. There were strong positive correlations to delta activity and a 
negative correlation to alpha activity in keeping with previously published research 
(40). This shows that the DFA scaling exponent increases with an EEG indicator of 
increased drowsiness, and decreases with increased alertness. 
The EEG slowing measured by using combined PSA densities were then compared with 
the novel method of the DFA. DFA has very good correlation to both PSA measures of 
EEG slowing (delta+theta/alpha+beta) as well as (theta/alpha) when assessed using 
Pearson’s correlation coefficient. The combined power densities of PSA showed 
consistently tighter correlation than the individual power densities measured. 
There were not adequate statistically significant results to say which EEG slowing 
measurement is the most sensitive in detecting performance impairment.  
The use of EEG as a measure of sleepiness or of performance ability should be explored 
further with more sensitive measures of performance, for example, extended driving 
tests as the results of this study did not yield adequate statistically significant results to 
draw a conclusion. 
However, the results are sufficiently convincing to use the ICA in place of manual 
scoring for artefact removal during DFA measurements. This is not recommended for 
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PSA as identical results were not obtained for both scoring systems and further 
validation in a group of patients with more positive results are required. 
5.5 Limitations 
The limitations are as follows: 
1. During manual scoring of the awake EEG, almost 50% of the epochs were 
excluded during the EO state. As there were only two minutes of recording in 
total per EO/EC state, 50% would include only one minute of recordings. This 
exclusion facilitated analysis of a clear signal but reduced the precision of the 
measurement. 
2. For some tasks, a greater time separation between EEG recording and 
performance testing may have attenuated any association between EEG and 
measured performance. While some tasks such as the driving task were 
performed within minutes of the EEG recording, many other tests were 
performed the next morning approximately 12 hours later. Timing of the EEG 
acquisition may also influence the test results as there is evidence to suggest a 
presence of diurnal variation in the cortical quantitative EEG (82, 83). 
3. Individual tests may not have been conducted in optimal conditions to show 
performance impairment in the patients tested. Firstly, some tasks were 
performed in the morning when the homeostatic and circadian drive to sleep was 
at its nadir. Secondly, the tasks may not have been sufficiently challenging. The 
AusEd task was applied for 30 minutes. While this testing duration has been 
shown to be sensitive to the effects of sleep loss (35), a recent study has found 
that a 90-minute drive to be better in revealing differences in performance 
between patients (81).  
4. All tests were performed in laboratory conditions that do not simulate real life 
occurrences, therefore, the results may have been adversely affected. 
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5.6 Future needs 
The future needs are as follows: 
1. Using an effective CPAP for a period of time and measuring the EEG slowing, 
comparing the pre- and post-treatment values would give a good indicator as to 
the benefit of treatment in improving vigilance.  
2. If manual artefact removal was to be used, increasing the duration of the awake 
EEG to 7.5 minutes as opposed to five minutes would give a larger sample of 
epochs to be included in the measurement, thus increasing the precision of the 
measurement. 
3. This current study has identified DFA as a measure that is robust to artefacts 
sustained during a recording done at rest while awake, however, the EEG testing 
should be performed while the task is being performed in order to accurately plot 
how EEG slowing is associated with performance. 
4. If a participant’s usual circumstances can be simulated, for example, alcohol 
intake and the usual number of hours in bed, more realistic measures of the 
performance testing can be acquired. 
5. More sensitive results would have been expected if the AusEd driving task was 
extended. 
6. This study group had an AHI ranging from 0 to 112. Patients with AHI <5 were 
not considered to have significant sleep disordered breathing. Hence, excluding 
patients with AHI <5 may have given performance data of a more robust OSA 
group. 
7. In this study, all patients diagnosed with OSA were invited to participate in the 
project. If a selective group was chosen with known daytime impairment such as 
previous MVA, higher ESS or higher AHI, the performance results may have 
been more significant. 
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6. CONCLUSION 
6.1 Comparison of manual versus ICA artefact removal 
methods 
In this study, two electroencephalographic artefact removal methods were compared: (i) 
manual ‘gold standard’; and (ii) automated method based on Independent Components 
Analysis. Ten EEG measurements were explored, of which eight used power spectral 
data measuring different EEG frequencies of delta (0.5-4Hz), theta (4-8Hz), alpha (8-12 
Hz) and beta (12-25Hz) in both eyes open and eyes closed states. The other two EEG 
measurements were from a novel measure, the DFA scaling exponent, which measures 
the randomness or fluctuations of the EEG signal. 
No single statistical method has been proven to be superior in identifying the 
interchangeability of two methods of measurement. Combined impressions from a 
number of statistical tests were encouraged to draw clinical conclusions. When 
comparing manual versus ICA artefact removal methods by using a paired t-test, there 
was a statistically significant difference between the two measurements in eight of the 
10 EEG waveforms measured. However, the calculated effect sizes and the difference 
between the means were small. The only exception to this was the comparison for beta 
power EO state, which showed a large effect size. The Bland-Altman plots 
demonstrated a tight scatter around the mean difference in all EEG measurements 
except for beta power EO. The examination of the beta power EO plot showed that the 
measurements are scattered around the mean, but with a higher mean difference. There 
is also systematic bias that would explain the higher effect size noted previously. Since 
the beta frequency range is of less interest in investigating drowsiness with changes 
more frequently described in the lower frequencies, this would not affect the overall 
measurements of drowsiness, which is measured by slower waves of delta and theta.  
Pearson’s correlation coefficient and intra-class correlation coefficient for agreement 
demonstrated good agreement between the manual and ICA artefact removal methods in 
all 10 EEG measurements. A tighter relationship was demonstrated during the EC state 
compared to the EO state, and correlation was greater for DFA than for PSA 
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measurements. This implies that the influence of artefact on the measured parameters 
was less during the eyes closed state, and also that DFA was a more robust 
measurement compared to PSA metrics in withstanding artefacts.  
The intra-class correlation further strengthens this argument and showed a near perfect 
absolute agreement between the ICA and manual artefact removal methods in 
measuring DFA. This correlation was less strong for PSA metrics.  
Overall, DFA and PSA look at the same effect (EEG slowing or drowsiness) in different 
ways, measuring fluctuations of EEG versus measuring EEG frequency respectively. 
PSA metrics are vulnerable to the influence of artefacts as eye blinks and muscle 
movements create larger waves with slower frequencies similar to the delta wave 
frequency. In contrast, the novel EEG analysis method, DFA, is far superior to PSA 
metrics in withstanding artefact. This robustness was proven during comparison of the 
two artefact removal methods that showed perfect interchangeability when measuring 
DFA with either artefact removal method, but not PSA. 
Next, an attempt is made to look at the clinical applicability of the results obtained from 
the two artefact removal methods. To do this, each artefact removal method was 
correlated to the performance testing.  
With use of PSA, when a statistically significant correlation was observed a similar 
trend was observed regardless of whether artefact removal was performed automatically 
by ICA or manually, although the exact correlation coefficient numerical value was 
slightly different. 
With the use of DFA, when a statistically significant correlation is present, the manual 
and ICA methods derived identical results.  
Our group had previously validated the use of ICA by comparing DFA to performance 
testing in a group of normal controls using both methods of manual scoring and ICA, 
demonstrating comparable results (48). The result of this study where the ICA was used 
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in 83 patients with OSA is consistent with the previous results, and strengthens the 
validation of ICA use in OSA patients in giving similar results when using DFA.  
This current study shows that ICA and manual artefact removal can be interchangeably 
used in extracting DFA measurements with confidence.  
The PSA metrics have shown to be highly influenced by artefact, hence 
interchangeability of artefact removal methods is not advisable. When analysing PSA 
metrics, only the manual artefact removal method should be used. 
6.2 Comparison of EEG slowing with performance testing 
The battery of performance testing yielded weak but statistically significant positive 
results only with delta+theta/alpha+beta EC in tasks of AusEd driving test parameters of 
mean reaction time and median reaction time to trucks and spot the real word test, the 
total AHI, NREM AHI, arousal index and the DASS score for anxiety. When the 
correlations were explored further with scatter plots, it was evident that the above 
results were due to two influential outliers. Following removal of these outliers, no 
significant association between EEG slowing and the other variables was found.  
Hence, there were no significant correlations between the 10 EEG metrics examined, 14 
individual performance tests and the AusEd driving task. This is despite choosing a set 
of individual tests previously reported to demonstrate performance impairment in OSA 
patients. The lack of significant impairment in performance may be due to the lag time 
between the awake EEG recording that was done in the evening and performance tests 
that were conducted in the morning on the following day, the reduced homeostatic drive 
to sleep at the time of testing (9 am) and the modified laboratory conditions that would 
have either improved or disrupted the participant’s sleep, as well as using the AusEd 
driving task that was too short in duration, therefore, reducing its sensitivity to detect 
performance impairment. 
It is possible that measuring the awake EEG at a greater temporal proximity to task 
performance would give a better understanding of the electrophysiological state of the 
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brain at that time and hence provide a better indicator of the impairment of task 
performance. For example, if EEG were measured at the time of driving, a stronger 
association between EEG slowing and driving task performance may have been 
obtained. The main disadvantage of this strategy would be the increased artefacts that 
one would expect with eye blinking and head movement. We would expect data like 
this to be best analysed using a DFA scaling exponent due to its resilience to withstand 
artefacts. 
It is not known what causes EEG slowing in OSA patients. This study found that there 
was no relationship to subjective sleepiness, sleep study measures of arousal, nocturnal 
hypoxia or sleep apnoea severity, as defined by the AHI that would explain EEG 
slowing. 
The performance testing did not yield any statistically significant correlations with any 
measure of EEG slowing, hence, there is inadequate data to evaluate what method of 
EEG slowing is most sensitive to performance impairment.  
The novel DFA measurement is a robust measurement with minimal influence from 
artefacts. It is complementary to the currently used PSA metrics, especially during 
circumstances with increased artefacts. 
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APPENDICES 
Appendix 1 –Tables 
Table 1 Factors predisposing to OSA 
Factors Causes Example 
Obesity Menopause, lack of exercise, poor diet 
Hormonal factors Hypothyroidism 
Acromegaly 
Cushing’s syndrome 
Supine position  
Upper airway lesions Enlarged tonsils and adenoids 
Congenital laryngeal cysts and webs 
Crico-arytenoid arthritis 
Skeletal abnormality Retrognathia 
Micrognathia (Pierre Robin syndrome, 
Treacher –Collins syndrome) 
Marfan’s syndrome 
Mid face hypoplasia (Craniosynostes, 
Achondroplasia, Down’s syndrome 
Small upper 
airway 
Mucopolysaccharriodoses Hunter, Herler and Sachie sydnromes 
Sleep deprivation and sleep 
fragmentation 
 
Medication Benzodiazepam 
Opioids 
Alcohol  
Reduction of 
upper airway 
dilator muscle 
activity 
Neuromuscular conditions Strokes 
Cerebral palsy 
Arnold-Chairi malformations 
Prader-Willi Syndrome 
 
App 2 
Table 2 Epworth Sleepiness Scale 
 
 
Table 3 Karolinska Sleepiness Scale 
1 = extremely alert 
2 = very alert 
3 = alert 
4 = rather alert 
5 = neither alert nor sleepy 
6 = some signs of sleepiness 
7 = sleepy, but no effort to keep awake 
8 = sleepy, some effort to keep awake 
9 = very sleepy, great effort to keep awake 
 
App 3 
Table 4 Depression and Anxiety Stress Scale (DASS) 
1. I found it hard to wind down  0 1 2 3
2. I was aware of dryness of my mouth  0 1 2 3
3. I couldn’t seem to experience any positive feeling at all  0 1 2 3
4. I experienced breathing difficulty (e g, excessively rapid 
breathing, breathlessness in the absence of physical exertion) 
0 1 2 3
5. I found it difficult to work up the initiative to do things  0 1 2 3
6. I tended to over-react to situations  0 1 2 3
7. I experienced trembling (e g, in the hands)  0 1 2 3
8. I felt that I was using a lot of nervous energy  0 1 2 3
9. I was worried about situations in which I might panic and 
make a fool of myself 
0 1 2 3
10. I felt that I had nothing to look forward to  0 1 2 3
11. I found myself getting agitated  0 1 2 3
12. I found it difficult to relax  0 1 2 3
13. I felt down-hearted and blue  0 1 2 3
14. I was intolerant of anything that kept me from getting on 
with what I was doing 
0 1 2 3
15. I felt I was close to panic  0 1 2 3
16. I was unable to become enthusiastic about anything  0 1 2 3
17. I felt I wasn’t worth much as a person  0 1 2 3
18. I felt that I was rather touchy  0 1 2 3
19. I was aware of the action of my heart in the absence of 
physical exertion (e.g., sense of heart rate increase, heart 
missing a beat)  
0 1 2 3
20. I felt scared without any good reason  0 1 2 3
21. I felt that life was meaningless  0 1 2 3
 
0 Did not apply to me at all Never 
1 Applied to me to some degree or some of the time Sometimes 
2 Applied to me to a considerable degree, or a good part of the time Often 
3 Applied to me very much, or most of the time Almost always 
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Table 5 Functional Outcome of Sleep Questionnaire (FOSQ) 
FOSQ Test 
 Note: In this questionnaire, when the words “sleep” or “tired are used, it describes the 
feeling that you can’t keep your eyes open, your head is droopy, that you want to nod off 
or that you feel the urge to nap. These words do not refer to the tired or fatigued feeling 
you may have after you exercised. 
FOSQ questions are answered using numbers from 0 to 4 (see answer key below ): 
0= I don’t do this activity for other reasons 
1= Yes, extreme 
2= Yes, moderate 
3= Yes, a little, 
4=No  
 
 
 
Q1) Do you generally have difficulty concentrating on things you do because you are sleepy 
or tired? 
 0     1     2     3     4  
Q2) Do you generally have difficulty remembering things because you are sleepy or tired? 
 0     1     2     3     4  
Q3) Do you have difficulty finishing a meal because you become sleepy or tired? 
 0     1     2     3     4  
Q4) Do you have difficulty working on a hobby (for example: sewing, collecting, gardening) 
because you are sleepy or tired? 
 0     1     2     3     4  
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Q5) Do you have difficulty doing work around the house (for example: cleaning house, 
doing laundry, taking out the trash, repair work) because you are sleep or tired? 
 0     1     2     3     4  
Q6) Do you have difficulty operating a motor vehicle for short distances (less than 100 
miles) because you become sleepy or tired? 
 0     1     2     3     4  
Q7) Do you have difficulty operating a motor vehicle for long distances (greater than 100 
miles) because you become sleepy or tired? 
 0     1     2     3     4  
Q8) Do you have difficulty getting things done because you are too sleepy or tired to drive 
or take public transportation? 
 0     1     2     3     4  
Q9) Do you have difficulty take care of financial affairs and doing paperwork (for example: 
writing checks, paying bills, keeping financial records, filling out tax forms, etc.) 
because you are sleepy or tired? 
 0     1     2     3     4  
Q10) Do you have difficulty performing employed or volunteer work because you are sleepy 
or tired? 
 0     1     2     3     4  
Q11) Do you have difficulty maintaining a telephone conversation because you become 
sleepy or tired? 
 0     1     2     3     4  
Q12) Do you have difficulty visiting with you family or friends in your home because you 
become sleepy or tired? 
 0     1     2     3     4  
Q13) Do you have difficulty visiting with your family or friends in their homes because you 
become sleepy or tired? 
 0     1     2     3     4  
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Q14) Do you have difficulty doing things for your family or friends because you become 
sleepy or tired? 
 0     1     2     3     4  
 
(For Question 15, answer using only 1, 2, 3 or 4)  
Q15) Has your relationship with family, friends or work colleagues been affected because you 
are sleepy or tired? 
 1     2     3     4  
Q16) Do you have difficulty exercising or participating in a sporting activity because you are 
too sleepy or tired? 
 0     1     2     3     4  
Q17) Do you have difficulty watching a movie or videotape because you become sleepy or 
tired? 
 0     1     2     3     4  
Q18) Do you have difficulty enjoying the theatre or a lecture because you become sleepy or 
tired? 
 0     1     2     3     4  
Q19) Do you have difficulty enjoying a concert because you become sleepy or tired? 
 0     1     2     3     4  
Q20) Do you have difficulty watching television because you are sleepy or tired? 
 0     1     2     3     4  
Q21) Do you have difficulty participating in religious services, meeting or a group club 
because you are sleepy or tired? 
 0     1     2     3     4  
Q22) Do you have difficulty being as active as you want to be in the evening because you 
are sleepy or tired? 
 0     1     2     3     4  
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Q23) Do you have difficulty being as active as you want to be in the morning because you 
are sleepy or tired? 
 0     1     2     3     4  
Q24) Do you have difficulty being as active as you want to be in the afternoon because you 
are sleepy or tired? 
 0     1     2     3     4  
Q25) Do you have difficulty keeping a pace with others your own age because you are 
sleepy or tired? 
 0     1     2     3     4  
Q26) How would you rate yourself in your general level of activity?  
 0     1     2     3     4 
Q27) Has your intimate or sexual relationship been affected because you are sleepy or tired? 
 0     1     2     3     4  
Q28) Has your desire for intimacy or sex been affected because you are sleepy or tired? 
 0     1     2     3     4  
Q29) Has your ability to become sexually aroused been affected because you are sleepy or 
tired? 
 0     1     2     3     4  
Q30) Has your ability to have an orgasm been affected because you are sleep or tired? 
 0     1     2     3     4  
 
Table 6 Correlations between DFA with performance test (manual and ICA) 
DFA Eyes Open ICA Eyes Open Manual 
Eyes Closed 
ICA 
Eyes Closed 
Manual 
Finger tapping 
test 
r=0.41 
p<0.01 
r=0.41 
p<0.01 
r=0.27 
p=0.08 
r=0.29 
p=0.14 
Four choice 
reaction time 
r=-0.26 
p<0.05 
r=-0.17 
p=0.2 
r=-0.26 
p<0.05 
r=-0.26 
p<0.05 
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Table 7 Correlation between EEG slowing and AusEd driving simulation test  
Steering deviation 
EEG slowing 
Centre of the left 
lane 
Median lane 
position 
Speed deviation 
outside the 
60-80km/h zone 
Mean reaction 
time (braking in 
response to 
trucks) 
Standard 
deviation of 
reaction time 
Median reaction 
time 
Number of 
crashes 
Delta+theta/ 
alpha+betaEO 
r=-0.14 
p=0.2 
r=-0.12 
p=0.3 
     
Delta+theta/ 
alpha+betaEC 
r=0.12 
p=0.3 
r=0.16 
p=0.2 
r=0.08 
p=0.5 
r=. 296 
p=0.01 
r=-0.06 
p=0.6 
r=. 302 
p<0.01 
r=0.08 
p=0.5 
Theta/alpha EO r=-0.15 
p=0.2 
r=0.06 
p=0.6 
r=-0.1 
p=0.4 
r=-0.08 
p=0.5 
r=0.01 
p=0.9 
r=-0.11 
p=0.4 
r=0.12 
p=0.3 
Theta/alpha EC r=-0.07 
p=0.5 
r=0.11 
p=0.4 
r=-0.17 
p=0.2 
r=0.14 
p=0.2 
r=-0.03 
p=0.8 
r=0.13 
p=0.3 
r=0.15 
p=0.2 
DFA SE EO  r=-0.13 
p=0.3 
r=0.02 
p=0.9 
r=-0.13 
p=0.3 
r=-0.12 
p=0.3 
r=-0.14 
p=0.2 
r=-0.13 
p=0.3 
r=0.22 
p=0.1 
DFA SE EC r=0.02 
p=0.9 
r=0.04 
p=0.7 
r=-0.08 
p=0.5 
r=0.11 
p=0.3 
r=-0.03 
p=0.8 
r=0.10 
p=0.4 
r=0.08 
p=0.5 
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Table 8 Correlation between EEG slowing and sleep study data 
EEG slowing Sleep efficiency Arousal index Proportion of time below 90% NREM RDI REM RDI Total RDI 
Minimum 
saturations 
Delta+Theta/ 
Alpha+Beta) (EO) 
r=0.05 
p>0.05 
r=-0.17 
p>0.05 
r=-0.17 
p>0.05 
r=-0.21 
p>0.05 
r=-0.23 
p>0.05 
r=-0. 22 
p>0.05 
r=0.26 
p>0.05 
 Delta+Theta/ 
Alpha+Beta (EC) 
r=0.08 
p>0.05 
r=0.3 
p<0.01 
r=0.09 
p>0.05 
r=0.27 
p=0.01 
r=0.18 
p>0.05 
r=0.26 
p=0.01 
r=-0.09 
p>0.05 
Theta/alpha (EO) r=0.06 
p>0.05 
r=-0.29 
p>0.05 
r=-0.17 
p>0.05 
r=-0.33 
p>0.05 
r=-0.28 
p>0.05 
r=-0.34 
p>0.05 
r=0.19 
p>0.05 
That/alpha (EC) r=0.02 
p>0.05 
r=-0.02 
p>0.05 
r=-0.004 
p>0.05 
r=0.03 
p>0.05 
r=-0.01 
p>0.05 
r=0.02 
p>0.05 
r=-0.005 
p>0.05 
DFA (EO) r=0.08 
p>0.05 
r=-0.12 
p>0.05 
r=-0.08 
p>0.05 
r=-0.14 
p>0.05 
r=-.24 
p>0.05 
r=-0.15 
p>0.05 
r=0.09 
p>0.05 
DFA (EC) r=0.04 
p>0.05 
r=0.14 
p>0.05 
r=0.08 
p>0.05 
r=0.18 
p>0.05 
r=0.05 
p>0.05 
r=0.17 
p>0.05 
r=-0.11 
p>0.05 
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Table 9 Correlation between measurements of EEG slowing and self-rated 
questionnaires on sleepiness 
Measurement for EEG slowing ESS KSS 
Delta+theta/alpha+beta EO  r=-0.2 
p=0.06 
r=0.2 
p=0.2 
Delta+theta/alpha+beta EC  r=-0.2 
p=0.07 
r=-0.1 
p=0.4 
Theta/alpha manual EO r=-0.1 
p=0.5 
r=0.1 
p=0.4 
Theta/alpha manual EC r=-0.3 
p=0.01 
r=0.01 
p=0.9  
DFA scaling exponent EC r=-0.1 
p=0.3 
r=-0.01 
p=0.9 
DFA scaling exponent EO r=-0.2 
p=0.1 
r=0.1 
p=0.3 
 
 
Table 10 Correlation between EEG slowing and depression and anxiety scale 
and functional assessment of sleep questionnaire 
 FOSQ 
vigilance 
DASS score for 
depression 
DASS score for 
anxiety 
DASS score for 
stress 
Delta+theta/ 
alpha+beta EO 
r=-0.01 
p=0.92 
r=-0.04 
p=0.72 
r=-0.06 
p=0.6 
r=-0.03 
p=0.78 
Delta+theta/ 
alpha+beta EC 
r=0.09 
p=0.41 
r=0.09 
p=0.41 
r=0.297 
p<0.01 
r=0.11 
p=0.33 
Theta/alpha 
EO 
r=0.07 
p=0.51 
r=-0.14 
p=0.2 
r=-0.11 
p=0.34 
r=0.03 
p=0.77 
Theta/alpha 
EC 
r=0.22 
p=0.05 
r=0.05 
p=0.64 
r=0.06 
p=0.58 
r=0.03 
p=0.78 
KDT SE 
EO  
r=-0.05 
p=0.68 
r=0.04 
p=0.72 
r=0.01 
p=0.91 
r=0.04 
p=0.75 
KDT SE 
EC 
r=-0.02 
p=0.89 
r=0.09 
p=0.43 
r=0.17 
p=0.13 
r=0.06 
p=0.6 
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Table 11 (Part 1: Tests for attention) Correlation between EEG slowing and tests for performance 
Sustained attention 
 
Finger 
tapping 
dominant hand 
Finger 
tapping 
non-dominant 
hand 
4-choice reaction 
time 
Switching 
attention 
trail marking 
part A 
Longest sequence 
correctly completed 
No of incorrect 
responses 
Visual attention 
timing 
Delta+theta/ 
alpha+beta EO  
r=0.1 
p=0.3 
r=0.2 
p=0.1 
r=-0.1 
p=0.5 
r=0.12 
p=0.4 
r=-0.06 
p=0.6 
r=0.01 
p=0.9 
r=-0.15 
p=0.56 
Delta+theta/ 
alpha+beta EC 
r=0.03 
p=0.8 
r=0.1 
p=0.5 
r=-0.2 
p=0.2 
r=-0.03 
p=0.8 
r=-0.02 
p=0.9 
r=-0.03 
p=0.8 
r=-0.03 
p=0.78 
Theta/alpha EO r=0.2 
p=0.1 
r=0.22 
p=0.2 
r=-0.1 
p=0.5 
r=0.08 
p=0.6 
r=-0.04 
p=0.8 
r=0.04 
p=0.7 
r=-0.04 
p=0.7 
Theta/alpha EC r=0.06 
p=0.6 
r=0.13 
p=0.4 
r=-0.16 
p=0.2 
r=-0.2 
p=0.3 
r=-0.03 
p=0.8 
r= -0.02 
p=0.9 
r=-0.09 
p=0.45 
DFA EO r=0.2 
p=0.1 
r=0.4 
p=0.01 
r=-0.17 
p=0.2 
r=-0.1 
p=0.4 
r=0.09 
p=0.4 
r=0.163 
p=0.18 
r=0.11 
p=0.4 
DFA EC r=0.2 
p=0.3 
r=0.2 
p=0.1 
R-0.250 
p<0.05 
r=-0.2 
p=0.1 
r=0.08 
p=0.5 
r=-0.01 
P-0.9 
r=0.06 
p=0.6 
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Table 12 (Part 2: Tests for intelligence) Correlation between EEG slowing and tests for performance 
Stroop test Tower of London  
 
 
 
Switching 
attention 
trail marking Part 
B 
No. ofwords 
identified 
 
No. of colours 
identified 
 
No. of moves 
Average time 
taken to complete 
the task 
Maze test 
Delta+theta/ 
alpha+beta EO  
r=0.0 
p=1.0 
r=0.04 
p=0.7 
r=-0.02 
p=0.9 
r=0.02 
p=0.8 
r=-0.05 
p=0.6 
r=-0.03 
p=0.8 
Delta+theta/ 
alpha+beta EC 
r=0.07 
p=0.6 
r=0.04 
p=0.7 
r=-0.06 
p=0.6 
r=0.08 
p=0.5 
r=-0.07 
p=0.5 
r=0.1 
p=0.4 
Theta/alpha EO 
 
r=0.002 
p=0.98 
r=0.14 
p=0.25 
r=0.06 
p=0.6 
r=0.1 
p=0.3 
r=-0.01 
p=0.4 
r=0.05 
p=0.69 
Theta/alpha EC 
 
r=-0.01 
p=0.9 
r=0.08 
p=0.5 
r=0.05 
p=0.7 
r=0.1 
p=0.4 
r=-0.2 
p=0.2 
r=0.02 
p=0.9 
DFA Scaling 
Exponent EO 
r=0.03 
p=0.8 
r=0.27 
p<0.05 
r=0.1 
p=0.3 
r=0.1 
p=0.4 
r=-0.1 
p=0.4 
r=-0.02 
p=0.8 
DFA Scaling 
Exponent EC 
r=0.0 
p=1.0 
r=0.2 
p=0.11 
r=0.11 
p=0.4 
r=0.08 
p=0.5 
r=-0.09 
p=0.5 
r=-0.01 
p=0.94 
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Table 13 (Part 3: Tests for memory and verbal fluency) Correlation between EEG slowing and tests for performance 
Memory recall Word generation 
 
Span of 
visual 
memory 
Digit span R-digit spans Words 
correctly 
recognised as 
from the list 
No of words 
recalled over 
trials 1-4 
No of words 
recalled after 
25 mins 
FAS test 
 
Animal test 
 
 
Spot the real 
word test 
Delta+theta/ 
alpha+beta EO  
r=-0.02 
p=0.9 
r=0.05 
p=0.6 
r=-0.05 
p=0.7 
r=-0.1 
p=0.2 
r=0.2 
p<0.05 
r=0.1 
p=0.3 
r=0.1 
p=0.5 
r=0.07 
p=0.5 
r=-0.04 
p=0.7 
Delta+theta/ 
alpha+beta EC 
r=-0.09 
p=0.45 
r=-0.02 
p=0.9 
r=-0.2 
p=0.1 
r=-0.2 
p=0.1 
r=0.01 
p=0.9 
r=-0.2 
p=0.1 
r=-0.03 
p=0.8 
r=-0.03 
p=0.7 
r=-0.25 
p<0.05 
Theta/alpha EO r=-0.02 
p=0.9 
r=0.06 
p=0.6 
r=-0.12 
p=0.2 
r=0.01 
p=0.9 
r=0.03 
p=0.8 
r=0.04 
p=0.8 
r=-0.04 
p=0.7 
r=-0.04 
p=0.7 
r=-0.02 
p=0.8 
Theta/alpha EC r=-0.04 
p=0.7 
r=0.05 
p=0.6 
r=-0.09 
p=0.4 
r=-0.1 
p=0.6 
r=-0.04 
p=0.73 
r=0.04 
p=0.8 
r=-0.09 
p=0.4 
r=-0.09 
p=0.4 
r=-0.03 
p=0.8 
 DFA EO r=-0.01 
p=0.94 
r=0.1 
p=0.4 
r=-0.08 
p=0.5 
r=-0.08 
p=0.5 
r=0.08 
p=0.5 
r=0.02 
p=0.9 
-0.046 
r=0.1 
p=0.4 
r=0.1 
p=0.4 
r=-0.1 
p=0.4 
DFA EC r=-0.05 
p=0.7 
r=0.1 
p=0.2 
r=-0.07 
p=0.5 
r=-0.001 
p=0.9 
r=0.03 
p=0.8 
r=-0.05 
p=0.7 
r=0.1 
p=0.6 
r=0.06 
p=0.5 
r=-0.1 
p=0.4 
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